Drug Name | Pathway ID | Pathway name | P-value | No. of gene members | UniProt AC | Gene name | Detail of Coexpression | |
---|
Irbesartan | hsa00020 | Citrate cycle (TCA cycle) | 3.41E-02 | 2 | P50213, O14521 | IDH3A, SDHD | More | | Irbesartan | hsa00030 | Pentose phosphate pathway | 2.25E-03 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | | Irbesartan | hsa00040 | Pentose and glucuronate interconversions | 9.59E-03 | 2 | P15121, P14550 | AKR1B1, AKR1A1 | More | | Irbesartan | hsa00052 | Galactose metabolism | 1.06E-03 | 2 | P06280, O43451 | GLA, MGAM | More | | Irbesartan | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | | Irbesartan | hsa00071 | Fatty acid degradation | 3.65E-03 | 4 | O75521, P00325, P11766, P33121 | ECI2, ADH1B, ADH5, ACSL1 | More | | Irbesartan | hsa00190 | Oxidative phosphorylation | 1.04E-05 | 3 | Q16718, Q13488, O14521 | NDUFA5, TCIRG1, SDHD | More | | Irbesartan | hsa00220 | Arginine biosynthesis | 6.98E-04 | 3 | P15104, P05089, P49448 | GLUL, ARG1, GLUD2 | More | | Irbesartan | hsa00230 | Purine metabolism | 1.83E-03 | 3 | P21589, P20839, Q02153 | NT5E, IMPDH1, GUCY1B3 | More | | Irbesartan | hsa00240 | Pyrimidine metabolism | 1.94E-03 | 3 | P21589, P32320, P04183 | NT5E, CDA, TK1 | More | | Irbesartan | hsa00260 | Glycine, serine and threonine metabolism | 1.99E-02 | 1 | P22557 | ALAS2 | More | | Irbesartan | hsa00310 | Lysine degradation | 2.86E-02 | 2 | Q96KQ7, Q02809 | EHMT2, PLOD1 | More | | Irbesartan | hsa00500 | Starch and sucrose metabolism | 5.62E-10 | 4 | O43451, P46976, P35573, P06737 | MGAM, GYG1, AGL, PYGL | More | | Irbesartan | hsa00510 | N-Glycan biosynthesis | 3.15E-02 | 2 | P15907, Q9NR34 | ST6GAL1, MAN1C1 | More | | Irbesartan | hsa00512 | Mucin type O-glycan biosynthesis | 3.78E-02 | 2 | O95395, Q8N4A0 | GCNT3, GALNT4 | More | | Irbesartan | hsa00520 | Amino sugar and nucleotide sugar metabolism | 4.15E-05 | 3 | Q16222, Q9Y223, P06865 | UAP1, GNE, HEXA | More | | Irbesartan | hsa00524 | Neomycin, kanamycin and gentamicin biosynthesis | 2.03E-02 | 1 | P35557 | GCK | More | | Irbesartan | hsa00561 | Glycerolipid metabolism | 5.58E-04 | 3 | P15121, P14550, Q86XP1 | AKR1B1, AKR1A1, DGKH | More | | Irbesartan | hsa00564 | Glycerophospholipid metabolism | 2.00E-02 | 4 | P48651, Q9Y6K0, P35790, Q9Y259 | PTDSS1, CEPT1, CHKA, CHKB | More | | Irbesartan | hsa00565 | Ether lipid metabolism | 1.66E-05 | 2 | Q9Y6K0, Q8N661 | CEPT1, TMEM86B | More | | Irbesartan | hsa00590 | Arachidonic acid metabolism | 3.85E-02 | 2 | P11712, P09960 | CYP2C9, LTA4H | More | | Irbesartan | hsa00591 | Linoleic acid metabolism | 1.29E-03 | 1 | P11712 | CYP2C9 | More | | Irbesartan | hsa00600 | Sphingolipid metabolism | 2.65E-03 | 3 | Q9BX95, Q06136, P15289 | SGPP1, FVT1, ARSA | More | | Irbesartan | hsa00603 | Glycosphingolipid biosynthesis - globo and isoglobo series | 6.13E-05 | 2 | P06865, O75752 | HEXA, B3GALNT1 | More | | Irbesartan | hsa00604 | Glycosphingolipid biosynthesis - ganglio series | 2.46E-02 | 2 | P06865, Q9H4F1 | HEXA, ST6GALNAC4 | More | | Irbesartan | hsa00630 | Glyoxylate and dicarboxylate metabolism | 3.82E-08 | 3 | P40925, P40926, P15104 | MDH1, MDH2, GLUL | More | | Irbesartan | hsa00730 | Thiamine metabolism | 5.62E-10 | 3 | Q9Y6K8, P05186, P24666 | AK5, ALPL, ACP1 | More | | Irbesartan | hsa00740 | Riboflavin metabolism | 4.03E-02 | 1 | P24666 | ACP1 | More | | Irbesartan | hsa00760 | Nicotinate and nicotinamide metabolism | 6.37E-04 | 1 | P21589 | NT5E | More | | Irbesartan | hsa00770 | Pantothenate and CoA biosynthesis | 4.81E-07 | 3 | O95498, O95497, Q9NRN7 | VNN2, VNN1, AASDHPPT | More | | Irbesartan | hsa00785 | Lipoic acid metabolism | 4.32E-02 | 1 | Q9Y234 | LIPT1 | More | | Irbesartan | hsa00790 | Folate biosynthesis | 4.74E-02 | 2 | P07101, P42330 | TH, AKR1C3 | More | | Irbesartan | hsa00830 | Retinol metabolism | 2.20E-02 | 4 | P00325, P11766, Q9BPW9, O75911 | ADH1B, ADH5, DHRS9, DHRS3 | More | | Irbesartan | hsa00920 | Sulfur metabolism | 3.18E-02 | 1 | Q16762 | TST | More | | Irbesartan | hsa00970 | Aminoacyl-tRNA biosynthesis | 2.48E-08 | 4 | O95363, P54136, P14868, Q15046 | FARS2, RARS1, DARS, KARS | More | | Irbesartan | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 9.14E-03 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Irbesartan | hsa00982 | Drug metabolism - cytochrome P450 | 9.14E-03 | 2 | P11712, P78417 | CYP2C9, GSTO1 | More | | Irbesartan | hsa00983 | Drug metabolism - other enzymes | 7.62E-05 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | | Irbesartan | hsa01100 | Metabolic pathways | 5.09E-03 | 36 | Q9NR34, Q9Y234, P05089, Q6ZQY3, P32320, Q02153, P20839, P22748, P55809, P06280, Q16875, O43286, O43451, Q9Y6K0, P05186, P24666, Q86XP1, P14550, Q9HCC0, P33121, Q9UHK6, Q86VZ5, Q9BVK2, P57054, Q9UNP4, Q9BX95, P37837, P32321, Q9BPW9, O75911, Q9UHY7, P43490, P46976, P06737, Q99437, Q9NVH6 | MAN1C1, LIPT1, ARG1, GADL1, CDA, GUCY1B3, IMPDH1, CA4, OXCT1, GLA, PFKFB3, B4GALT5, MGAM, CEPT1, ALPL, ACP1, DGKH, AKR1A1, MCCC2, ACSL1, AMACR, SGMS1, ALG8, PIGP, ST3GAL5, SGPP1, TALDO1, DCTD, DHRS9, DHRS3, ENOPH1, PBEF1, GYG1, PYGL, ATP6V0B, TMLHE | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9NR34 | MAN1C1 | Mannosyl-oligosaccharide 1,2-alpha-mannosidase IC | -0.716 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9Y234 | LIPT1 | Lipoyltransferase 1, mitochondrial | 0.738 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q6ZQY3 | GADL1 | Acidic amino acid decarboxylase GADL1 | 0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32320 | CDA | Cytidine deaminase | 0.701 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q02153 | GUCY1B3 | Guanylate cyclase soluble subunit beta-1 | -0.741 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | P20839 | IMPDH1 | Inosine-5'-monophosphate dehydrogenase 1 | 0.788 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P22748 | CA4 | Carbonic anhydrase 4 | 0.767 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P55809 | OXCT1 | Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial | -0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06280 | GLA | Alpha-galactosidase A | 0.714 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16875 | PFKFB3 | 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 | 0.849 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43286 | B4GALT5 | Beta-1,4-galactosyltransferase 5 | 0.917 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O43451 | MGAM | Maltase-glucoamylase | 0.871 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9Y6K0 | CEPT1 | Choline/ethanolaminephosphotransferase 1 | 0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05186 | ALPL | Alkaline phosphatase, tissue-nonspecific isozyme | 0.901 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24666 | ACP1 | Low molecular weight phosphotyrosine protein phosphatase | -0.832 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q86XP1 | DGKH | Diacylglycerol kinase eta | -0.792 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | P14550 | AKR1A1 | Aldo-keto reductase family 1 member A1 | 0.733 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9HCC0 | MCCC2 | Methylcrotonoyl-CoA carboxylase beta chain, mitochondrial | -0.782 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P33121 | ACSL1 | Long-chain-fatty-acid--CoA ligase 1 | 0.886 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9UHK6 | AMACR | Alpha-methylacyl-CoA racemase | -0.768 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q86VZ5 | SGMS1 | Phosphatidylcholine:ceramide cholinephosphotransferase 1 | -0.78 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9BVK2 | ALG8 | Probable dolichyl pyrophosphate Glc1Man9GlcNAc2 alpha-1,3-glucosyltransferase | -0.754 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P57054 | PIGP | Phosphatidylinositol N-acetylglucosaminyltransferase subunit P | -0.881 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UNP4 | ST3GAL5 | Lactosylceramide alpha-2,3-sialyltransferase | -0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BX95 | SGPP1 | Sphingosine-1-phosphate phosphatase 1 | -0.743 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | P37837 | TALDO1 | Transaldolase | 0.746 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P32321 | DCTD | Deoxycytidylate deaminase | -0.748 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9BPW9 | DHRS9 | Dehydrogenase/reductase SDR family member 9 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75911 | DHRS3 | Short-chain dehydrogenase/reductase 3 | -0.81 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q9UHY7 | ENOPH1 | Enolase-phosphatase E1 | -0.737 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P46976 | GYG1 | Glycogenin-1 | 0.817 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P06737 | PYGL | Glycogen phosphorylase, liver form | 0.863 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q99437 | ATP6V0B | V-type proton ATPase 21 kDa proteolipid subunit c'' | 0.72 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q9NVH6 | TMLHE | Trimethyllysine dioxygenase, mitochondrial | -0.799 |
| Irbesartan | hsa01230 | Biosynthesis of amino acids | 3.13E-03 | 6 | P51854, P60891, Q99707, P50213, P05089, P37837 | TKTL1, PRPS1, MTR, IDH3A, ARG1, TALDO1 | More | | Irbesartan | hsa01523 | Antifolate resistance | 1.72E-04 | 4 | P41440, Q92820, P04818, P01375 | SLC19A1, GGH, TYMS, TNF | More | | Irbesartan | hsa01524 | Platinum drug resistance | 1.13E-02 | 5 | P10415, Q13489, P78417, P23025, P43246 | BCL2, BIRC3, GSTO1, XPA, MSH2 | More | | Irbesartan | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | | Irbesartan | hsa03008 | Ribosome biogenesis in eukaryotes | 4.44E-04 | 7 | Q9NYH9, P19784, P67870, P78345, Q9BVP2, O15381, Q9GZY0 | UTP6, CSNK2A2, CSNK2B, RPP38, GNL3, NVL, NXF2; NXF2B | More | | Irbesartan | hsa03010 | Ribosome | 1.60E-02 | 9 | P30050, P40429, P62906, P62917, Q9H0U6, P36578, P05386, P62249, P23396 | RPL12, RPL13A, RPL10A, RPL8, MRPL18, RPL4, RPLP1, RPS16, RPS3 | More | | Irbesartan | hsa03013 | RNA transport | 4.77E-08 | 21 | O14980, P52298, Q09161, O14893, P61326, P38919, Q15287, Q9UBU9, P37198, Q7Z3B4, P35658, P63279, Q14152, P55884, O15371, O75822, P78345, P20042, Q14240, Q9Y6A5, P51114 | XPO1, NCBP2, NCBP1, GEMIN2, MAGOH, EIF4A3, RNPS1, NXF1, NUP62, NUP54, NUP214, UBE2I, EIF3A, EIF3B, EIF3D, EIF3J, RPP38, EIF2S2, EIF4A2, TACC3, FXR1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P21462 | FPR1 | fMet-Leu-Phe receptor | O14980 | XPO1 | Exportin-1 | -0.742 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.888 | P21462 | FPR1 | fMet-Leu-Phe receptor | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | -0.874 | P51684 | CCR6 | C-C chemokine receptor type 6 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.924 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | 0.742 | P21462 | FPR1 | fMet-Leu-Phe receptor | Q09161 | NCBP1 | Nuclear cap-binding protein subunit 1 | -0.78 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.853 | P21462 | FPR1 | fMet-Leu-Phe receptor | O14893 | GEMIN2 | Gem-associated protein 2 | -0.87 | P51684 | CCR6 | C-C chemokine receptor type 6 | O14893 | GEMIN2 | Gem-associated protein 2 | 0.771 | P21462 | FPR1 | fMet-Leu-Phe receptor | P61326 | MAGOH | Protein mago nashi homolog | -0.835 | P51684 | CCR6 | C-C chemokine receptor type 6 | P61326 | MAGOH | Protein mago nashi homolog | 0.704 | P49768 | PSEN1 | Presenilin-1 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | 0.808 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15287 | RNPS1 | RNA-binding protein with serine-rich domain 1 | 0.756 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q9UBU9 | NXF1 | Nuclear RNA export factor 1 | 0.723 | P49768 | PSEN1 | Presenilin-1 | P37198 | NUP62 | Nuclear pore glycoprotein p62 | -0.716 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.774 | P21462 | FPR1 | fMet-Leu-Phe receptor | Q7Z3B4 | NUP54 | Nucleoporin p54 | -0.903 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q7Z3B4 | NUP54 | Nucleoporin p54 | 0.811 | P49768 | PSEN1 | Presenilin-1 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.768 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.725 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35658 | NUP214 | Nuclear pore complex protein Nup214 | -0.751 | P21462 | FPR1 | fMet-Leu-Phe receptor | P35658 | NUP214 | Nuclear pore complex protein Nup214 | 0.971 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.736 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.734 | P21462 | FPR1 | fMet-Leu-Phe receptor | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | -0.89 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q14152 | EIF3A | Eukaryotic translation initiation factor 3 subunit A | 0.701 | P49768 | PSEN1 | Presenilin-1 | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.71 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P55884 | EIF3B | Eukaryotic translation initiation factor 3 subunit B | -0.731 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | O15371 | EIF3D | Eukaryotic translation initiation factor 3 subunit D | 0.77 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.837 | P21462 | FPR1 | fMet-Leu-Phe receptor | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | -0.953 | P51684 | CCR6 | C-C chemokine receptor type 6 | O75822 | EIF3J | Eukaryotic translation initiation factor 3 subunit J | 0.711 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.852 | P51684 | CCR6 | C-C chemokine receptor type 6 | P78345 | RPP38 | Ribonuclease P protein subunit p38 | 0.861 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P20042 | EIF2S2 | Eukaryotic translation initiation factor 2 subunit 2 | 0.733 | P21462 | FPR1 | fMet-Leu-Phe receptor | Q14240 | EIF4A2 | Eukaryotic initiation factor 4A-II | -0.721 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.812 | P21462 | FPR1 | fMet-Leu-Phe receptor | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | 0.904 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q9Y6A5 | TACC3 | Transforming acidic coiled-coil-containing protein 3 | -0.732 | P21462 | FPR1 | fMet-Leu-Phe receptor | P51114 | FXR1 | Fragile X mental retardation syndrome-related protein 1 | -0.713 |
| Irbesartan | hsa03020 | RNA polymerase | 3.74E-06 | 5 | P30876, P24928, P62487, Q9GZM3, P52435 | POLR2B, POLR2A, POLR2G, POLR2J2, POLR2J | More | | Irbesartan | hsa03022 | Basal transcription factors | 3.52E-03 | 3 | O00268, Q5H9L4, Q15544 | TAF4, TAF7L, TAF11 | More | | Irbesartan | hsa03030 | DNA replication | 1.48E-02 | 3 | P49005, P33993, P15927 | POLD2, MCM7, RPA2 | More | | Irbesartan | hsa03040 | Spliceosome | 2.58E-12 | 22 | Q14562, O43143, O60508, Q99633, P17844, P08579, Q15427, P26368, P52298, P51991, P38159, P61978, Q13595, Q07955, Q01130, P84103, Q13243, Q9UMS4, P11142, Q9Y2W2, O43447, O75643 | DHX8, DHX15, CDC40, PRPF18, DDX5, SNRPB2, SF3B4, U2AF2, NCBP2, HNRPA3, RBMX, HNRPK, TRA2A, SFRS1, SFRS2, SFRS3, SFRS5, PRPF19, HSPA8, WBP11, PPIH, ASCC3L1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.708 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | 0.781 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.75 | P46091 | GPR1 | Chemerin-like receptor 2 | Q14562 | DHX8 | ATP-dependent RNA helicase DHX8 | -0.819 | P29375 | JARID1A | Lysine-specific demethylase 5A | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | 0.794 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.841 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.76 | P46091 | GPR1 | Chemerin-like receptor 2 | O43143 | DHX15 | ATP-dependent RNA helicase DHX15 | -0.816 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.837 | P29375 | JARID1A | Lysine-specific demethylase 5A | O60508 | CDC40 | Pre-mRNA-processing factor 17 | 0.875 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.812 | P46091 | GPR1 | Chemerin-like receptor 2 | O60508 | CDC40 | Pre-mRNA-processing factor 17 | -0.778 | P46091 | GPR1 | Chemerin-like receptor 2 | Q99633 | PRPF18 | Pre-mRNA-splicing factor 18 | -0.711 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.73 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.702 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08579 | SNRPB2 | U2 small nuclear ribonucleoprotein B'' | -0.822 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q15427 | SF3B4 | Splicing factor 3B subunit 4 | 0.71 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P26368 | U2AF2 | Splicing factor U2AF 65 kDa subunit | -0.751 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P52298 | NCBP2 | Nuclear cap-binding protein subunit 2 | 0.72 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P51991 | HNRPA3 | Heterogeneous nuclear ribonucleoprotein A3 | 0.787 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P38159 | RBMX | RNA-binding motif protein, X chromosome | 0.733 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.827 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P61978 | HNRPK | Heterogeneous nuclear ribonucleoprotein K | 0.784 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.722 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.74 | P46091 | GPR1 | Chemerin-like receptor 2 | Q13595 | TRA2A | Transformer-2 protein homolog alpha | -0.753 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | 0.725 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.757 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q07955 | SFRS1 | Serine/arginine-rich splicing factor 1 | -0.749 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.835 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | 0.862 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.798 | P46091 | GPR1 | Chemerin-like receptor 2 | Q01130 | SFRS2 | Serine/arginine-rich splicing factor 2 | -0.746 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84103 | SFRS3 | Serine/arginine-rich splicing factor 3 | -0.773 | P29375 | JARID1A | Lysine-specific demethylase 5A | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | 0.732 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.71 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13243 | SFRS5 | Serine/arginine-rich splicing factor 5 | -0.822 | P46091 | GPR1 | Chemerin-like receptor 2 | Q9UMS4 | PRPF19 | Pre-mRNA-processing factor 19 | 0.703 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.709 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | -0.802 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q9Y2W2 | WBP11 | WW domain-binding protein 11 | -0.743 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.761 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O43447 | PPIH | Peptidyl-prolyl cis-trans isomerase H | -0.766 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | -0.745 |
| Irbesartan | hsa03050 | Proteasome | 1.53E-03 | 1 | P55036 | PSMD4 | More | | Irbesartan | hsa03060 | Protein export | 1.20E-03 | 2 | P37108, Q15005 | SRP14, SPCS2 | More | | Irbesartan | hsa03430 | Mismatch repair | 4.38E-02 | 1 | P20585 | MSH3 | More | | Irbesartan | hsa03450 | Non-homologous end-joining | 3.17E-03 | 2 | Q9NP87, P13010 | POLM, XRCC5 | More | | Irbesartan | hsa03460 | Fanconi anemia pathway | 6.19E-03 | 3 | Q9BXW9, O94782, P07992 | FANCD2, USP1, ERCC1 | More | | Irbesartan | hsa04012 | ErbB signaling pathway | 3.74E-02 | 3 | P21860, Q13557, O14944 | ERBB3, CAMK2D, EREG | More | | Irbesartan | hsa04014 | Ras signaling pathway | 2.36E-02 | 8 | P42338, P20827, P49767, Q13009, Q7LDG7, P63218, P50151, P19174 | PIK3CB, EFNA1, VEGFC, TIAM1, RASGRP2, GNG5, GNG10, PLCG1 | More | | Irbesartan | hsa04015 | Rap1 signaling pathway | 2.00E-05 | 16 | P20827, P49767, P06213, P63261, Q96FS4, P11215, P25116, Q8TEU7, Q13009, O00522, Q7LDG7, P42338, P0DP23, P08514, P17252, P19174 | EFNA1, VEGFC, INSR, ACTG1, SIPA1, ITGAM, F2R, RAPGEF6, TIAM1, KRIT1, RASGRP2, PIK3CB, CALM1, ITGA2B, PRKCA, PLCG1 | More | | Irbesartan | hsa04020 | Calcium signaling pathway | 5.60E-09 | 16 | Q96DU7, P45880, Q16566, Q13557, P17252, P21860, O15399, P25116, P0DP23, P05141, P12236, P51828, P26678, P63092, P23634, P49767 | ITPKC, VDAC2, CAMK4, CAMK2D, PRKCA, ERBB3, GRIN2D, F2R, CALM1, SLC25A5, SLC25A6, ADCY7, PLN, GNAS, ATP2B4, VEGFC | More | | Irbesartan | hsa04022 | cGMP-PKG signaling pathway | 1.00E-04 | 11 | P61586, P26678, Q99941, P18848, P23634, Q8WYR1, P51828, P05141, P12236, P45880, P0DP24 | RHOA, PLN, CREBL1, ATF4, ATP2B4, PIK3R5, ADCY7, SLC25A5, SLC25A6, VDAC2, CALM2 | More | | Irbesartan | hsa04024 | cAMP signaling pathway | 3.94E-04 | 11 | P63092, P42338, P26678, P0DP23, P23634, P61586, Q16566, Q13370, O15399, P25116, Q13009 | GNAS, PIK3CB, PLN, CALM1, ATP2B4, RHOA, CAMK4, PDE3B, GRIN2D, F2R, TIAM1 | More | | Irbesartan | hsa04060 | Cytokine-cytokine receptor interaction | 3.25E-05 | 19 | P27930, P14778, P26842, Q9UHF4, Q13651, P48551, P16871, P78552, P25024, Q9UBD3, P47992, P02775, O75509, P09341, P32248, P51684, P18510, P09603, P01730 | IL1R2, IL1R1, CD27, IL20RA, IL10RA, IFNAR2, IL7R, IL13RA1, CXCR1, XCL2, XCL1, PPBP, TNFRSF21, CXCL1, CCR7, CCR6, IL1RN, CSF1, CD4 | More | | Irbesartan | hsa04061 | Viral protein interaction with cytokine and cytokine receptor | 1.26E-05 | 7 | P51684, P32248, P09341, P02775, P47992, Q9UBD3, Q9UHF4 | CCR6, CCR7, CXCL1, PPBP, XCL1, XCL2, IL20RA | More | | Irbesartan | hsa04062 | Chemokine signaling pathway | 1.43E-04 | 17 | P25024, P25025, P47992, Q9UBD3, P09769, P07948, P42338, P19174, P63218, P50151, P43250, P49407, Q08881, Q7LDG7, Q13009, P49841, Q8WYR1 | CXCR1, CXCR2, XCL1, XCL2, FGR, LYN, PIK3CB, PLCG1, GNG5, GNG10, GRK6, ARRB1, ITK, RASGRP2, TIAM1, GSK3B, PIK3R5 | More | | Irbesartan | hsa04064 | NF-kappa B signaling pathway | 2.09E-09 | 24 | P10415, P51617, Q12933, O00463, Q13546, P14778, P01584, P01375, P19174, Q04759, Q9UDY8, Q13077, P19784, Q16548, P07948, P06239, Q8WV28, Q13315, P63279, P24522, Q8NHW4, P09341, Q06643, Q9NQC7 | BCL2, IRAK1, TRAF2, TRAF5, RIPK1, IL1R1, IL1B, TNF, PLCG1, PRKCQ, MALT1, TRAF1, CSNK2A2, BCL2A1, LYN, LCK, BLNK, ATM, UBE2I, GADD45A, CCL4L2, CXCL1, LTB, CYLD | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.744 | P51684 | CCR6 | C-C chemokine receptor type 6 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.84 | P51684 | CCR6 | C-C chemokine receptor type 6 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.722 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | Q12933 | TRAF2 | TNF receptor-associated factor 2 | 0.871 | Q04759 | PRKCQ | Protein kinase C theta type | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.81 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.932 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.945 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.868 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.728 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.804 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.869 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.796 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.73 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.768 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | 0.82 | Q04759 | PRKCQ | Protein kinase C theta type | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.76 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.958 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.875 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P07948 | LYN | Tyrosine-protein kinase Lyn | -0.742 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P06239 | LCK | Tyrosine-protein kinase Lck | 0.791 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q8WV28 | BLNK | B-cell linker protein | -0.704 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q8WV28 | BLNK | B-cell linker protein | -0.816 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P63279 | UBE2I | SUMO-conjugating enzyme UBC9 | 0.756 | Q04759 | PRKCQ | Protein kinase C theta type | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.846 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.796 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 | P51684 | CCR6 | C-C chemokine receptor type 6 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.712 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | Q04759 | PRKCQ | Protein kinase C theta type | P09341 | CXCL1 | Growth-regulated alpha protein | -0.885 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.802 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | Q06643 | LTB | Lymphotoxin-beta | 0.774 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.799 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q9NQC7 | CYLD | Ubiquitin carboxyl-terminal hydrolase CYLD | 0.825 |
| Irbesartan | hsa04066 | HIF-1 signaling pathway | 3.40E-02 | 3 | Q09472, P07195, P10415 | EP300, LDHB, BCL2 | More | | Irbesartan | hsa04068 | FoxO signaling pathway | 3.52E-02 | 1 | Q96BR1 | SGK3 | More | | Irbesartan | hsa04070 | Phosphatidylinositol signaling system | 4.87E-04 | 7 | P0DP23, Q14643, P42338, P23743, O14732, P27987, P17252 | CALM1, ITPR1, PIK3CB, DGKA, IMPA2, ITPKB, PRKCA | More | | Irbesartan | hsa04071 | Sphingolipid signaling pathway | 2.46E-05 | 10 | P17252, P21453, Q9H228, P01375, Q13362, Q16537, Q9BX95, P04637, P10415, Q9UQC2 | PRKCA, S1PR1, EDG8, TNF, PPP2R5C, PPP2R5E, SGPP1, TP53, BCL2, GAB2 | More | | Irbesartan | hsa04072 | Phospholipase D signaling pathway | 7.71E-04 | 5 | Q92529, P61586, O14986, Q14344, P63092 | SHC3, RHOA, PIP5K1B, GNA13, GNAS | More | | Irbesartan | hsa04080 | Neuroactive ligand-receptor interaction | 2.76E-02 | 6 | Q15722, P21453, O00398, P25116, P21462, Q16581 | LTB4R, S1PR1, P2RY10, F2R, FPR1, C3AR1 | More | | Irbesartan | hsa04110 | Cell cycle | 2.12E-06 | 12 | Q9UJX4, P06493, O60566, Q09472, P24522, O75293, P04637, P49918, P30304, P33981, P42773, P01106 | ANAPC5, CDK1, BUB1B, EP300, GADD45A, GADD45B, TP53, CDKN1C, CDC25A, TTK, CDKN2C, MYC | More | | Irbesartan | hsa04114 | Oocyte meiosis | 3.54E-05 | 5 | Q9Y6D9, P51812, Q02750, P16298, Q17RY0 | MAD1L1, RPS6KA3, MAP2K1, PPP3CB, CPEB4 | More | | Irbesartan | hsa04120 | Ubiquitin mediated proteolysis | 2.51E-03 | 6 | Q14145, Q13042, P62837, Q15751, O95071, P0CG47 | KEAP1, CDC16, UBE2D2, HERC1, UBR5, UBB | More | | Irbesartan | hsa04122 | Sulfur relay system | 3.18E-02 | 1 | Q16762 | TST | More | | Irbesartan | hsa04137 | Mitophagy - animal | 6.72E-04 | 4 | P19784, P67870, Q07817, P0CG47 | CSNK2A2, CSNK2B, BCL2L1, UBB | More | | Irbesartan | hsa04140 | Autophagy - animal | 2.86E-03 | 6 | Q9NQL2, P22694, Q14643, P10415, Q9H1Y0, Q04759 | RRAGD, PRKACB, ITPR1, BCL2, ATG5, PRKCQ | More | | Irbesartan | hsa04141 | Protein processing in endoplasmic reticulum | 2.94E-04 | 8 | P18848, Q15437, Q99941, O75460, P11142, Q9H3Z4, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, ERN1, HSPA8, DNAJC5, HSP90AA1, SAR1A | More | | Irbesartan | hsa04142 | Lysosome | 1.46E-02 | 7 | P06865, P22304, P38571, Q13510, P07602, Q9NRA2, P61916 | HEXA, IDS, LIPA, ASAH1, PSAP, SLC17A5, NPC2 | More | | Irbesartan | hsa04144 | Endocytosis | 2.89E-03 | 8 | P0DMV8, Q9H444, O75351, P62491, Q96B97, Q15438, Q14161, Q9UMY4 | HSPA1A, CHMP4B, VPS4B, RAB11A, SH3KBP1, PSCD1, GIT2, SNX12 | More | | Irbesartan | hsa04145 | Phagosome | 5.64E-07 | 13 | O75015, P63261, Q15080, P14598, Q13509, P68371, Q13488, P05164, P78380, O60603, P35443, P27824, P13765 | FCGR3B, ACTG1, NCF4, NCF1, TUBB3, TUBB2C, TCIRG1, MPO, OLR1, TLR2, THBS4, CANX, HLA-DOB | More | | Irbesartan | hsa04150 | mTOR signaling pathway | 2.23E-03 | 6 | P42338, Q02750, Q9NQL2, P51812, Q13322, P49841 | PIK3CB, MAP2K1, RRAGD, RPS6KA3, GRB10, GSK3B | More | | Irbesartan | hsa04151 | PI3K-Akt signaling pathway | 2.31E-06 | 25 | P62753, P42338, P21860, P43657, O43521, P27348, P20827, O14944, P49767, P07900, P08238, Q15831, Q8WYR1, P63218, P50151, O15335, Q13751, P22105, P14784, Q99941, P18848, O00141, Q6ZUJ8, P30281, O95988 | RPS6, PIK3CB, ERBB3, P2RY5, BCL2L11, YWHAQ, EFNA1, EREG, VEGFC, HSP90AA1, HSP90AB1, STK11, PIK3R5, GNG5, GNG10, CHAD, LAMB3, TNXB, IL2RB, CREBL1, ATF4, SGK, PIK3AP1, CCND3, TCL1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P62753 | RPS6 | 40S ribosomal protein S6 | 0.722 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P62753 | RPS6 | 40S ribosomal protein S6 | 0.709 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P21860 | ERBB3 | Receptor tyrosine-protein kinase erbB-3 | -0.731 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O43521 | BCL2L11 | Bcl-2-like protein 11 | 0.724 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P27348 | YWHAQ | 14-3-3 protein theta | 0.711 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P27348 | YWHAQ | 14-3-3 protein theta | 0.833 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P27348 | YWHAQ | 14-3-3 protein theta | 0.708 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P20827 | EFNA1 | Ephrin-A1 | 0.715 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O14944 | EREG | Proepiregulin [Cleaved into: Epiregulin | -0.778 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 0.718 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | 1 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q15831 | STK11 | Serine/threonine-protein kinase STK11 | 0.731 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.76 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q8WYR1 | PIK3R5 | Phosphoinositide 3-kinase regulatory subunit 5 | 0.752 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O15335 | CHAD | Chondroadherin | 0.795 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P22105 | TNXB | Tenascin-X | 0.802 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P22105 | TNXB | Tenascin-X | 0.777 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.802 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.777 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.781 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.783 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | P07900 | HSP90AA1 | Heat shock protein HSP 90-alpha | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.709 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O00141 | SGK | Serine/threonine-protein kinase Sgk1 | 0.755 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | Q6ZUJ8 | PIK3AP1 | Phosphoinositide 3-kinase adapter protein 1 | 0.728 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O95988 | TCL1B | T-cell leukemia/lymphoma protein 1B | 0.719 |
| Irbesartan | hsa04210 | Apoptosis | 3.78E-05 | 14 | P04637, P10415, O76075, P01375, Q9NR28, O75460, P24522, Q16548, Q13077, O43521, P43234, Q9UBR2, P18848, Q14643 | TP53, BCL2, DFFB, TNF, DIABLO, ERN1, GADD45A, BCL2A1, TRAF1, BCL2L11, CTSO, CTSZ, ATF4, ITPR1 | More | | Irbesartan | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Irbesartan | hsa04213 | Longevity regulating pathway - multiple species | 2.82E-02 | 3 | Q08828, P51828, P0DMV8 | ADCY1, ADCY7, HSPA1A | More | | Irbesartan | hsa04217 | Necroptosis | 5.40E-08 | 19 | P01375, P01568, P48023, Q13489, Q13546, P42224, Q14765, P08238, P15104, P05141, P01584, P0C0S5, Q6FI13, Q99878, Q93077, P10415, Q9H444, O43633, Q08752 | TNF, IFNA21, FASLG, BIRC3, RIPK1, STAT1, STAT4, HSP90AB1, GLUL, SLC25A5, IL1B, H2AFZ, H2AC18; H2AC19, H2AC14, HIST1H2AC, BCL2, CHMP4B, CHMP2A, PPID | More | | Irbesartan | hsa04218 | Cellular senescence | 4.79E-02 | 4 | P01106, O75293, P30304, P06493 | MYC, GADD45B, CDC25A, CDK1 | More | | Irbesartan | hsa04261 | Adrenergic signaling in cardiomyocytes | 2.59E-05 | 12 | P63092, P51828, Q99941, P18848, P26678, Q16537, P0DP23, Q13557, P17252, P10415, P20020, P23634 | GNAS, ADCY7, CREBL1, ATF4, PLN, PPP2R5E, CALM1, CAMK2D, PRKCA, BCL2, ATP2B1, ATP2B4 | More | | Irbesartan | hsa04270 | Vascular smooth muscle contraction | 6.96E-03 | 6 | P0DP23, Q08828, P51828, P35579, P35749, P35318 | CALM1, ADCY1, ADCY7, MYH9, MYH11, ADM | More | | Irbesartan | hsa04310 | Wnt signaling pathway | 2.00E-04 | 4 | P61586, P17612, P19784, P67870 | RHOA, PRKACA, CSNK2A2, CSNK2B | More | | Irbesartan | hsa04330 | Notch signaling pathway | 2.46E-03 | 3 | Q92542, P49768, P46531 | NCSTN, PSEN1, NOTCH1 | More | | Irbesartan | hsa04340 | Hedgehog signaling pathway | 2.36E-03 | 3 | P49841, P17612, P22694 | GSK3B, PRKACA, PRKACB | More | | Irbesartan | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | | Irbesartan | hsa04360 | Axon guidance | 2.47E-03 | 7 | P16333, P20827, O95631, P42338, P07332, P23528, P19174 | NCK1, EFNA1, NTN1, PIK3CB, FES, CFL1, PLCG1 | More | | Irbesartan | hsa04370 | VEGF signaling pathway | 2.22E-06 | 3 | P16298, Q05397, Q02750 | PPP3CB, PTK2, MAP2K1 | More | | Irbesartan | hsa04371 | Apelin signaling pathway | 1.00E-02 | 7 | P63218, P50151, Q8WYR1, Q14814, Q14344, Q13485, P84022 | GNG5, GNG10, PIK3R5, MEF2D, GNA13, SMAD4, SMAD3 | More | | Irbesartan | hsa04380 | Osteoclast differentiation | 1.86E-05 | 14 | Q9NQC7, Q9UQC2, Q16539, P23458, P06239, P42338, P01584, P14778, O75015, Q8WV28, P01375, Q15080, Q8N149, P78324 | CYLD, GAB2, MAPK14, JAK1, LCK, PIK3CB, IL1B, IL1R1, FCGR3B, BLNK, TNF, NCF4, LILRA2, SIRPA | More | | Irbesartan | hsa04390 | Hippo signaling pathway | 3.06E-04 | 6 | P63261, Q13485, P04628, Q9UJU2, O43623, Q13489 | ACTG1, SMAD4, WNT1, LEF1, SNAI2, BIRC3 | More | | Irbesartan | hsa04510 | Focal adhesion | 3.86E-03 | 9 | Q15942, O14986, P17252, P61586, Q16363, Q13489, P10415, P49767, P63261 | ZYX, PIP5K1B, PRKCA, RHOA, LAMA4, BIRC3, BCL2, VEGFC, ACTG1 | More | | Irbesartan | hsa04512 | ECM-receptor interaction | 3.73E-02 | 2 | P07359, P08514 | GP1BA, ITGA2B | More | | Irbesartan | hsa04514 | Cell adhesion molecules | 8.19E-03 | 3 | P16109, P56750, O00501 | SELP, CLDN17, CLDN5 | More | | Irbesartan | hsa04520 | Adherens junction | 1.66E-04 | 7 | Q13485, Q9UJU2, O43623, P19784, P67870, P61586, P63261 | SMAD4, LEF1, SNAI2, CSNK2A2, CSNK2B, RHOA, ACTG1 | More | | Irbesartan | hsa04530 | Tight junction | 2.47E-05 | 5 | Q8TEU7, P16989, P56750, O00501, Q14247 | RAPGEF6, CSDA, CLDN17, CLDN5, CTTN | More | | Irbesartan | hsa04540 | Gap junction | 1.53E-03 | 4 | P17252, Q13509, P68371, Q14643 | PRKCA, TUBB3, TUBB2C, ITPR1 | More | | Irbesartan | hsa04610 | Complement and coagulation cascades | 2.48E-07 | 7 | P25116, P09871, P00734, P0C0L4, P12259, P11215, P05107 | F2R, C1S, F2, C4A, F5, ITGAM, ITGB2 | More | | Irbesartan | hsa04611 | Platelet activation | 2.96E-06 | 7 | P25116, Q9Y490, P08514, Q15746, Q8WYR1, P17612, P07359 | F2R, TLN1, ITGA2B, MYLK, PIK3R5, PRKACA, GP1BA | More | | Irbesartan | hsa04612 | Antigen processing and presentation | 6.84E-06 | 9 | P13765, P48382, P26715, P26717, Q07444, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KLRC1, KLRC2, KLRC3, KLRD1, KLRC4, CD8A, TNF | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P48382 | RFX5 | DNA-binding protein RFX5 | 0.826 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P48382 | RFX5 | DNA-binding protein RFX5 | -0.743 | Q04759 | PRKCQ | Protein kinase C theta type | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.803 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.726 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.714 | Q04759 | PRKCQ | Protein kinase C theta type | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.803 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.726 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.714 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.829 | Q04759 | PRKCQ | Protein kinase C theta type | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.849 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.78 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.715 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O43908 | KLRC4 | NKG2-F type II integral membrane protein | -0.721 | Q04759 | PRKCQ | Protein kinase C theta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.861 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.763 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.722 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 |
| Irbesartan | hsa04613 | Neutrophil extracellular trap formation | 2.34E-08 | 30 | P19174, P17252, P57764, P16109, P11215, O60603, P05164, P08246, P05107, Q9UM07, Q13547, Q92769, P0C0S5, Q6FI13, Q93077, P62807, P33778, Q16778, O60814, P68431, P14598, Q15080, P08311, O75015, P21730, P08514, P21462, P07359, O43315, Q16539 | PLCG1, PRKCA, GSDMDC1, SELP, ITGAM, TLR2, MPO, ELA2, ITGB2, PADI4, HDAC1, HDAC2, H2AFZ, H2AC18; H2AC19, HIST1H2AC, HIST1H2BC, H2BC3, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, NCF1, NCF4, CTSG, FCGR3B, C5AR1, ITGA2B, FPR1, GP1BA, AQP9, MAPK14 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.804 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P17252 | PRKCA | Protein kinase C alpha type | 0.849 | P51684 | CCR6 | C-C chemokine receptor type 6 | P17252 | PRKCA | Protein kinase C alpha type | 0.738 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P57764 | GSDMDC1 | Gasdermin-D | 0.725 | P18054 | ALOX12 | Polyunsaturated fatty acid lipoxygenase ALOX12 | P16109 | SELP | P-selectin | 0.819 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P11215 | ITGAM | Integrin alpha-M | -0.862 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P11215 | ITGAM | Integrin alpha-M | 0.734 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | O60603 | TLR2 | Toll-like receptor 2 | -0.729 | P51684 | CCR6 | C-C chemokine receptor type 6 | O60603 | TLR2 | Toll-like receptor 2 | -0.767 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05164 | MPO | Myeloperoxidase | 0.719 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08246 | ELA2 | Neutrophil elastase | 0.702 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P08246 | ELA2 | Neutrophil elastase | -0.716 | P51684 | CCR6 | C-C chemokine receptor type 6 | P08246 | ELA2 | Neutrophil elastase | -0.706 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P05107 | ITGB2 | Integrin beta-2 | 0.769 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UM07 | PADI4 | Protein-arginine deiminase type-4 | 0.813 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | Q13547 | HDAC1 | Histone deacetylase 1 | 0.784 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q92769 | HDAC2 | Histone deacetylase 2 | -0.7 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q92769 | HDAC2 | Histone deacetylase 2 | 0.702 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P0C0S5 | H2AFZ | Histone H2A.Z | 0.785 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | -0.843 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q6FI13 | H2AC18; H2AC19 | Histone H2A type 2-A | -0.86 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | Q93077 | HIST1H2AC | Histone H2A type 1-C | -0.748 | P11712 | CYP2C9 | Cytochrome P450 2C9 | Q93077 | HIST1H2AC | Histone H2A type 1-C | 0.754 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | -0.888 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.753 | P51684 | CCR6 | C-C chemokine receptor type 6 | P33778 | H2BC3 | Histone H2B type 1-B | 0.704 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | -0.888 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.717 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | P62807 | HIST1H2BC | Histone H2B type 1-C/E/F/G/I | 0.753 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | Q16778 | HIST2H2BE | Histone H2B type 2-E | -0.881 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | O60814 | H2BC12 | Histone H2B type 1-K | -0.776 | P11712 | CYP2C9 | Cytochrome P450 2C9 | O60814 | H2BC12 | Histone H2B type 1-K | 0.728 | P18054 | ALOX12 | Polyunsaturated fatty acid lipoxygenase ALOX12 | O60814 | H2BC12 | Histone H2B type 1-K | 0.783 | Q99527 | GPER1 | G-protein coupled estrogen receptor 1 | O60814 | H2BC12 | Histone H2B type 1-K | 0.793 | P11712 | CYP2C9 | Cytochrome P450 2C9 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.845 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P68431 | H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | Histone H3.1 | 0.703 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.816 | P51684 | CCR6 | C-C chemokine receptor type 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.713 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.762 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.813 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.803 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08311 | CTSG | Cathepsin G | 0.744 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P21730 | C5AR1 | C5a anaphylatoxin chemotactic receptor 1 | 0.983 | P18054 | ALOX12 | Polyunsaturated fatty acid lipoxygenase ALOX12 | P08514 | ITGA2B | Integrin alpha-IIb | 0.941 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P21462 | FPR1 | fMet-Leu-Phe receptor | 0.839 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P21462 | FPR1 | fMet-Leu-Phe receptor | -0.726 | P51684 | CCR6 | C-C chemokine receptor type 6 | P21462 | FPR1 | fMet-Leu-Phe receptor | -0.7 | P18054 | ALOX12 | Polyunsaturated fatty acid lipoxygenase ALOX12 | P07359 | GP1BA | Platelet glycoprotein Ib alpha chain | 0.876 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O43315 | AQP9 | Aquaporin-9 | 0.934 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 |
| Irbesartan | hsa04614 | Renin-angiotensin system | 7.48E-03 | 4 | P50052, P15144, P08311, O75787 | AGTR2, ANPEP, CTSG, ATP6AP2 | More | | Irbesartan | hsa04621 | NOD-like receptor signaling pathway | 3.40E-02 | 8 | Q14643, P10599, P43490, O00463, P29728, P01375, P09341, P12838 | ITPR1, TXN, PBEF1, TRAF5, OAS2, TNF, CXCL1, DEFA4 | More | | Irbesartan | hsa04623 | Cytosolic DNA-sensing pathway | 6.28E-07 | 5 | P01584, P01568, Q13546, P25963, Q8NHW4 | IL1B, IFNA21, RIPK1, NFKBIA, CCL4L2 | More | | Irbesartan | hsa04625 | C-type lectin receptor signaling pathway | 9.91E-04 | 9 | Q9ULY5, P01584, Q9NQC7, P20749, Q14643, P01375, Q13191, P0DP24, Q16539 | CLEC4E, IL1B, CYLD, BCL3, ITPR1, TNF, CBLB, CALM2, MAPK14 | More | | Irbesartan | hsa04640 | Hematopoietic cell lineage | 1.22E-06 | 17 | P13612, P21926, P14778, P27930, P15144, P11836, P25063, P07766, P09693, P01732, P01730, P06127, P09564, P13765, P01375, P09603, P01584 | ITGA4, CD9, IL1R1, IL1R2, ANPEP, MS4A1, CD24, CD3E, CD3G, CD8A, CD4, CD5, CD7, HLA-DOB, TNF, CSF1, IL1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13612 | ITGA4 | Integrin alpha-4 | -0.797 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13612 | ITGA4 | Integrin alpha-4 | 0.774 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P13612 | ITGA4 | Integrin alpha-4 | 0.764 | P52732 | KIF11 | Kinesin-like protein KIF11 | P21926 | CD9 | CD9 antigen | -0.787 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.807 | Q04759 | PRKCQ | Protein kinase C theta type | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.733 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.726 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P15144 | ANPEP | Aminopeptidase N | 0.851 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P15144 | ANPEP | Aminopeptidase N | -0.757 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P11836 | MS4A1 | B-lymphocyte antigen CD20 | -0.71 | Q04759 | PRKCQ | Protein kinase C theta type | P25063 | CD24 | Signal transducer CD24 | -0.903 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P25063 | CD24 | Signal transducer CD24 | -0.839 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P52732 | KIF11 | Kinesin-like protein KIF11 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.724 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.777 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | Q04759 | PRKCQ | Protein kinase C theta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.861 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.781 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | P52732 | KIF11 | Kinesin-like protein KIF11 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.719 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.732 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.756 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P06127 | CD5 | T-cell surface glycoprotein CD5 | -0.739 | P52732 | KIF11 | Kinesin-like protein KIF11 | P09564 | CD7 | T-cell antigen CD7 | -0.886 | P06493 | CDK1 | Cyclin-dependent kinase 1 | P09564 | CD7 | T-cell antigen CD7 | -0.735 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P09564 | CD7 | T-cell antigen CD7 | 0.735 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P09603 | CSF1 | Macrophage colony-stimulating factor 1 | -0.715 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 |
| Irbesartan | hsa04650 | Natural killer cell mediated cytotoxicity | 2.17E-12 | 15 | P16298, P50591, P01375, P78314, P06239, O60880, P20963, Q02750, Q13241, P26718, O14931, O75015, P26717, Q07444, P26715 | PPP3CB, TNFSF10, TNF, SH3BP2, LCK, SH2D1A, CD247, MAP2K1, KLRD1, KLRK1, NCR3, FCGR3B, KLRC2, KLRC3, KLRC1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | P11511 | CYP19A1 | Aromatase | P50591 | TNFSF10 | Tumor necrosis factor ligand superfamily member 10 | 0.701 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P01375 | TNF | Tumor necrosis factor | 0.718 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.761 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P78314 | SH3BP2 | SH3 domain-binding protein 2 | 0.748 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.779 | Q04759 | PRKCQ | Protein kinase C theta type | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.855 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.823 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60880 | SH2D1A | SH2 domain-containing protein 1A | 0.862 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.751 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | O60880 | SH2D1A | SH2 domain-containing protein 1A | -0.788 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.722 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.771 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | Q04759 | PRKCQ | Protein kinase C theta type | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.849 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.82 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.852 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | 0.78 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.715 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q13241 | KLRD1 | Natural killer cells antigen CD94 | -0.701 | Q04759 | PRKCQ | Protein kinase C theta type | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.918 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.91 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.922 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | 0.767 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.842 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26718 | KLRK1 | NKG2-D type II integral membrane protein | -0.81 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | O14931 | NCR3 | Natural cytotoxicity triggering receptor 3 | 0.818 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.913 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.896 | Q04759 | PRKCQ | Protein kinase C theta type | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.803 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.846 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.943 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | 0.726 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.714 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26717 | KLRC2 | NKG2-C type II integral membrane protein | -0.721 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q07444 | KLRC3 | NKG2-E type II integral membrane protein | 0.829 | Q04759 | PRKCQ | Protein kinase C theta type | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.803 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.846 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.943 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | 0.726 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.714 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P26715 | KLRC1 | NKG2-A/NKG2-B type II integral membrane protein | -0.721 |
| Irbesartan | hsa04657 | IL-17 signaling pathway | 2.46E-05 | 8 | O00463, Q16539, P49841, P09341, P14780, P80188, P01375, P01584 | TRAF5, MAPK14, GSK3B, CXCL1, MMP9, LCN2, TNF, IL1B | More | | Irbesartan | hsa04658 | Th1 and Th2 cell differentiation | 1.02E-15 | 17 | Q04759, P07766, P20963, P09693, Q16539, P19174, P01730, P06239, P42224, Q14765, P23771, Q9UL17, P14784, P78504, P13765, P23458, Q13761 | PRKCQ, CD3E, CD247, CD3G, MAPK14, PLCG1, CD4, LCK, STAT1, STAT4, GATA3, TBX21, IL2RB, JAG1, HLA-DOB, JAK1, RUNX3 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | P32249 | GPR183 | G-protein coupled receptor 183 | Q04759 | PRKCQ | Protein kinase C theta type | 0.71 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.734 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.805 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.777 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.769 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.758 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P32249 | GPR183 | G-protein coupled receptor 183 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.864 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.812 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.804 | P32249 | GPR183 | G-protein coupled receptor 183 | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.713 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.756 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P06239 | LCK | Tyrosine-protein kinase Lck | 0.791 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.788 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.762 | Q04759 | PRKCQ | Protein kinase C theta type | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.746 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | -0.777 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q14765 | STAT4 | Signal transducer and activator of transcription 4 | 0.904 | Q04759 | PRKCQ | Protein kinase C theta type | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.867 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.763 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | P32249 | GPR183 | G-protein coupled receptor 183 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.927 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.849 | Q04759 | PRKCQ | Protein kinase C theta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.843 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.872 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.705 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.731 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.741 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P78504 | JAG1 | Protein jagged-1 | 0.907 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P32249 | GPR183 | G-protein coupled receptor 183 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.845 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.849 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.73 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | Q13761 | RUNX3 | Runt-related transcription factor 3 | 0.712 |
| Irbesartan | hsa04659 | Th17 cell differentiation | 3.95E-14 | 21 | Q04759, Q16539, P19174, P01730, P06239, P42224, P14784, P13765, P14778, Q9HBE5, P40189, Q9UL17, P23771, P84022, Q13485, P01584, P08238, P07766, P09693, P20963, P23458 | PRKCQ, MAPK14, PLCG1, CD4, LCK, STAT1, IL2RB, HLA-DOB, IL1R1, IL21R, IL6ST, TBX21, GATA3, SMAD3, SMAD4, IL1B, HSP90AB1, CD3E, CD3G, CD247, JAK1 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | P32249 | GPR183 | G-protein coupled receptor 183 | Q04759 | PRKCQ | Protein kinase C theta type | 0.71 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.734 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.804 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P32249 | GPR183 | G-protein coupled receptor 183 | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.713 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P01730 | CD4 | T-cell surface glycoprotein CD4 | 0.756 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P06239 | LCK | Tyrosine-protein kinase Lck | 0.791 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | P78508 | KCNJ10 | ATP-sensitive inward rectifier potassium channel 10 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.753 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.788 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.762 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.741 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P78508 | KCNJ10 | ATP-sensitive inward rectifier potassium channel 10 | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.829 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P32249 | GPR183 | G-protein coupled receptor 183 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.845 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.728 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | P78508 | KCNJ10 | ATP-sensitive inward rectifier potassium channel 10 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.877 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.764 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.807 | Q04759 | PRKCQ | Protein kinase C theta type | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.8 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9HBE5 | IL21R | Interleukin-21 receptor | 0.713 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 | Q04759 | PRKCQ | Protein kinase C theta type | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.843 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9UL17 | TBX21 | T-box transcription factor TBX21 | -0.872 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.884 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.705 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | Q9UL17 | TBX21 | T-box transcription factor TBX21 | 0.731 | Q04759 | PRKCQ | Protein kinase C theta type | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.867 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | -0.763 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.784 | P32249 | GPR183 | G-protein coupled receptor 183 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.927 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P23771 | GATA3 | Trans-acting T-cell-specific transcription factor GATA-3 | 0.849 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.805 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P78508 | KCNJ10 | ATP-sensitive inward rectifier potassium channel 10 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.819 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.838 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.777 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P32249 | GPR183 | G-protein coupled receptor 183 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.864 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.812 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.769 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.758 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 |
| Irbesartan | hsa04660 | T cell receptor signaling pathway | 4.28E-11 | 13 | P01375, Q9UDY8, Q04759, O95267, Q08881, P07766, P20963, P09693, P01732, Q13191, P06239, Q16539, P49841 | TNF, MALT1, PRKCQ, RASGRP1, ITK, CD3E, CD247, CD3G, CD8A, CBLB, LCK, MAPK14, GSK3B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P01375 | TNF | Tumor necrosis factor | 0.718 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9UDY8 | MALT1 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | 0.721 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q04759 | PRKCQ | Protein kinase C theta type | 0.803 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.734 | Q04759 | PRKCQ | Protein kinase C theta type | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.733 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.852 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.925 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.737 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | Q04759 | PRKCQ | Protein kinase C theta type | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.803 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.866 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 1 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | 0.752 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.746 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | -0.736 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.839 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.722 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.771 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.813 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.812 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.77 | Q04759 | PRKCQ | Protein kinase C theta type | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.861 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.781 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.803 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | 0.763 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P01732 | CD8A | T-cell surface glycoprotein CD8 alpha chain | -0.722 | Q04759 | PRKCQ | Protein kinase C theta type | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.767 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.803 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | 0.811 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.719 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q13191 | CBLB | E3 ubiquitin-protein ligase CBL-B | -0.734 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P06239 | LCK | Tyrosine-protein kinase Lck | 0.774 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.779 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.889 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.795 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.812 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.861 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.823 |
| Irbesartan | hsa04662 | B cell receptor signaling pathway | 2.89E-06 | 6 | P49841, P42338, P60033, P07948, P21854, Q8N149 | GSK3B, PIK3CB, CD81, LYN, CD72, LILRA2 | More | | Irbesartan | hsa04664 | Fc epsilon RI signaling pathway | 1.62E-04 | 7 | P01375, Q16539, P42338, Q9UQC2, P07948, P19174, P09917 | TNF, MAPK14, PIK3CB, GAB2, LYN, PLCG1, ALOX5 | More | | Irbesartan | hsa04666 | Fc gamma R-mediated phagocytosis | 8.04E-06 | 7 | P42338, P23528, P49006, P06396, O14494, P14598, P17252 | PIK3CB, CFL1, MARCKSL1, GSN, PLPP1, NCF1, PRKCA | More | | Irbesartan | hsa04668 | TNF signaling pathway | 1.99E-04 | 10 | P01375, O00463, Q16539, Q99941, P18848, P01584, P20749, P14780, P20333, O95429 | TNF, TRAF5, MAPK14, CREBL1, ATF4, IL1B, BCL3, MMP9, TNFRSF1B, BAG4 | More | | Irbesartan | hsa04672 | Intestinal immune network for IgA production | 1.62E-02 | 3 | P29965, P10747, P13765 | CD40LG, CD28, HLA-DOB | More | | Irbesartan | hsa04713 | Circadian entrainment | 3.41E-03 | 5 | P0DP23, P17252, P62873, Q14643, P63092 | CALM1, PRKCA, GNB1, ITPR1, GNAS | More | | Irbesartan | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | | Irbesartan | hsa04720 | Long-term potentiation | 5.78E-08 | 8 | P17252, Q16566, P16298, P0DP23, P51812, O15399, Q02750, Q14643 | PRKCA, CAMK4, PPP3CB, CALM1, RPS6KA3, GRIN2D, MAP2K1, ITPR1 | More | | Irbesartan | hsa04721 | Synaptic vesicle cycle | 1.98E-04 | 4 | Q13488, Q99437, P43005, P31645 | TCIRG1, ATP6V0B, SLC1A1, SLC6A4 | More | | Irbesartan | hsa04722 | Neurotrophin signaling pathway | 3.27E-02 | 3 | P49841, O43524, P48023 | GSK3B, FOXO3, FASLG | More | | Irbesartan | hsa04723 | Retrograde endocannabinoid signaling | 4.94E-02 | 2 | P48169, P62873 | GABRA4, GNB1 | More | | Irbesartan | hsa04724 | Glutamatergic synapse | 4.09E-06 | 8 | P48058, O15399, P43003, P63092, P62873, P63218, P50151, P15104 | GRIA4, GRIN2D, SLC1A3, GNAS, GNB1, GNG5, GNG10, GLUL | More | | Irbesartan | hsa04725 | Cholinergic synapse | 2.61E-05 | 11 | P51828, Q14643, P17252, P62873, P63218, P50151, P18848, Q16566, Q13557, P42338, P10415 | ADCY7, ITPR1, PRKCA, GNB1, GNG5, GNG10, ATF4, CAMK4, CAMK2D, PIK3CB, BCL2 | More | | Irbesartan | hsa04726 | Serotonergic synapse | 3.41E-03 | 5 | P63092, Q14643, P17252, P62873, P33260 | GNAS, ITPR1, PRKCA, GNB1, CYP2C18 | More | | Irbesartan | hsa04727 | GABAergic synapse | 1.56E-03 | 3 | P63218, P50151, P15104 | GNG5, GNG10, GLUL | More | | Irbesartan | hsa04728 | Dopaminergic synapse | 4.12E-03 | 9 | P14416, P63218, P50151, P49841, Q99941, P18848, Q16539, Q13557, P49407 | DRD2, GNG5, GNG10, GSK3B, CREBL1, ATF4, MAPK14, CAMK2D, ARRB1 | More | | Irbesartan | hsa04730 | Long-term depression | 3.52E-02 | 1 | Q14344 | GNA13 | More | | Irbesartan | hsa04742 | Taste transduction | 3.91E-02 | 1 | P17612 | PRKACA | More | | Irbesartan | hsa04744 | Phototransduction | 3.21E-04 | 2 | P62873, P0DP23 | GNB1, CALM1 | More | | Irbesartan | hsa04750 | Inflammatory mediator regulation of TRP channels | 1.99E-05 | 13 | P14778, P01584, Q08828, P51828, P22694, Q13557, Q16539, P42338, Q14643, P24723, Q04759, P0DP24, P0DP23 | IL1R1, IL1B, ADCY1, ADCY7, PRKACB, CAMK2D, MAPK14, PIK3CB, ITPR1, PRKCH, PRKCQ, CALM2, CALM1 | More | | Irbesartan | hsa04810 | Regulation of actin cytoskeleton | 2.58E-02 | 3 | Q15746, P08514, P25116 | MYLK, ITGA2B, F2R | More | | Irbesartan | hsa04910 | Insulin signaling pathway | 2.35E-02 | 3 | P22694, P06737, P49841 | PRKACB, PYGL, GSK3B | More | | Irbesartan | hsa04911 | Insulin secretion | 2.87E-07 | 5 | P51828, P63092, Q99941, P18848, Q13557 | ADCY7, GNAS, CREBL1, ATF4, CAMK2D | More | | Irbesartan | hsa04912 | GnRH signaling pathway | 8.90E-05 | 10 | P17252, P51828, P18848, Q13557, Q16539, Q9Y6R4, Q14643, P0DP24, P0DP23, P22694 | PRKCA, ADCY7, ATF4, CAMK2D, MAPK14, MAP3K4, ITPR1, CALM2, CALM1, PRKACB | More | | Irbesartan | hsa04913 | Ovarian steroidogenesis | 2.52E-02 | 1 | P06213 | INSR | More | | Irbesartan | hsa04914 | Progesterone-mediated oocyte maturation | 1.15E-05 | 7 | Q17RY0, P42338, Q13370, Q9Y6D9, P08238, P51812, Q02750 | CPEB4, PIK3CB, PDE3B, MAD1L1, HSP90AB1, RPS6KA3, MAP2K1 | More | | Irbesartan | hsa04915 | Estrogen signaling pathway | 7.24E-05 | 9 | Q99941, P18848, Q08828, P51828, P07900, P0DMV8, P11142, P0DP23, Q15788 | CREBL1, ATF4, ADCY1, ADCY7, HSP90AA1, HSPA1A, HSPA8, CALM1, NCOA1 | More | | Irbesartan | hsa04916 | Melanogenesis | 4.47E-03 | 4 | P0DP23, Q9UJU2, P17252, P04628 | CALM1, LEF1, PRKCA, WNT1 | More | | Irbesartan | hsa04918 | Thyroid hormone synthesis | 1.69E-03 | 4 | P51828, Q99941, P18848, P02768 | ADCY7, CREBL1, ATF4, ALB | More | | Irbesartan | hsa04919 | Thyroid hormone signaling pathway | 7.11E-03 | 4 | P49841, P22694, O60244, Q9NVC6 | GSK3B, PRKACB, MED14, MED17 | More | | Irbesartan | hsa04921 | Oxytocin signaling pathway | 4.19E-02 | 4 | P0DP23, P17252, Q16566, P63261 | CALM1, PRKCA, CAMK4, ACTG1 | More | | Irbesartan | hsa04923 | Regulation of lipolysis in adipocytes | 3.76E-02 | 1 | P06213 | INSR | More | | Irbesartan | hsa04924 | Renin secretion | 3.77E-02 | 2 | Q13370, P0DP23 | PDE3B, CALM1 | More | | Irbesartan | hsa04925 | Aldosterone synthesis and secretion | 1.25E-10 | 11 | Q14643, Q99941, P18848, P51828, P0DP23, P63092, P17252, Q16566, Q13557, P20020, P23634 | ITPR1, CREBL1, ATF4, ADCY7, CALM1, GNAS, PRKCA, CAMK4, CAMK2D, ATP2B1, ATP2B4 | More | | Irbesartan | hsa04926 | Relaxin signaling pathway | 5.00E-04 | 8 | P42338, P63218, P50151, Q99941, P18848, P49767, P51828, P49407 | PIK3CB, GNG5, GNG10, CREBL1, ATF4, VEGFC, ADCY7, ARRB1 | More | | Irbesartan | hsa04927 | Cortisol synthesis and secretion | 3.00E-04 | 4 | Q99941, P18848, P51828, P63092 | CREBL1, ATF4, ADCY7, GNAS | More | | Irbesartan | hsa04928 | Parathyroid hormone synthesis, secretion and action | 1.39E-03 | 5 | P51828, P63092, P61586, Q99941, P18848 | ADCY7, GNAS, RHOA, CREBL1, ATF4 | More | | Irbesartan | hsa04929 | GnRH secretion | 3.30E-03 | 2 | P42338, P49407 | PIK3CB, ARRB1 | More | | Irbesartan | hsa04930 | Type II diabetes mellitus | 3.14E-02 | 1 | P06213 | INSR | More | | Irbesartan | hsa04931 | Insulin resistance | 1.94E-02 | 3 | P01375, P49841, P06737 | TNF, GSK3B, PYGL | More | | Irbesartan | hsa04932 | Non-alcoholic fatty liver disease | 7.37E-06 | 10 | P01375, P49841, O43521, P18848, P48023, O75460, P01584, P13073, P12074, O95298 | TNF, GSK3B, BCL2L11, ATF4, FASLG, ERN1, IL1B, COX4I1, COX6A1, NDUFC2 | More | | Irbesartan | hsa04933 | AGE-RAGE signaling pathway in diabetic complications | 2.93E-03 | 7 | P84022, Q13485, P10415, P42338, P49767, P17252, P19174 | SMAD3, SMAD4, BCL2, PIK3CB, VEGFC, PRKCA, PLCG1 | More | | Irbesartan | hsa04934 | Cushing syndrome | 5.03E-08 | 6 | Q99941, P18848, P51828, P63092, O15169, Q13557 | CREBL1, ATF4, ADCY7, GNAS, AXIN1, CAMK2D | More | | Irbesartan | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | | Irbesartan | hsa04940 | Type I diabetes mellitus | 1.87E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Irbesartan | hsa04950 | Maturity onset diabetes of the young | 2.03E-02 | 1 | P35557 | GCK | More | | Irbesartan | hsa04960 | Aldosterone-regulated sodium reabsorption | 2.32E-03 | 2 | P06213, P48048 | INSR, KCNJ1 | More | | Irbesartan | hsa04962 | Vasopressin-regulated water reabsorption | 1.80E-02 | 2 | P62491, P46459 | RAB11A, NSF | More | | Irbesartan | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | | Irbesartan | hsa04966 | Collecting duct acid secretion | 5.23E-06 | 4 | Q13488, P02730, P00918, Q9Y666 | TCIRG1, SLC4A1, CA2, SLC12A7 | More | | Irbesartan | hsa04970 | Salivary secretion | 1.12E-04 | 7 | Q08828, P51828, Q14643, P20020, P23634, P17252, P0DP23 | ADCY1, ADCY7, ITPR1, ATP2B1, ATP2B4, PRKCA, CALM1 | More | | Irbesartan | hsa04971 | Gastric acid secretion | 1.87E-03 | 6 | P51828, P17252, P15311, P63261, P0DP23, Q13557 | ADCY7, PRKCA, VIL2, ACTG1, CALM1, CAMK2D | More | | Irbesartan | hsa04972 | Pancreatic secretion | 1.42E-03 | 5 | Q14643, P20020, P17252, P63092, P61586 | ITPR1, ATP2B1, PRKCA, GNAS, RHOA | More | | Irbesartan | hsa04973 | Carbohydrate digestion and absorption | 4.12E-03 | 2 | O43451, P42338 | MGAM, PIK3CB | More | | Irbesartan | hsa04976 | Bile secretion | 2.51E-03 | 5 | Q08828, P51828, P22694, P08183, Q14032 | ADCY1, ADCY7, PRKACB, ABCB1, BAAT | More | | Irbesartan | hsa04978 | Mineral absorption | 3.94E-02 | 2 | P23634, Q9BXS9 | ATP2B4, SLC26A6 | More | | Irbesartan | hsa05010 | Alzheimer disease | 8.47E-05 | 15 | Q92542, O15239, P05496, P13073, P12074, O75460, P0DP24, P01584, P18848, O15169, P05141, P12236, P45880, P43686, P62195 | NCSTN, NDUFA1, ATP5G1, COX4I1, COX6A1, ERN1, CALM2, IL1B, ATF4, AXIN1, SLC25A5, SLC25A6, VDAC2, PSMC4, PSMC5 | More | | Irbesartan | hsa05012 | Parkinson disease | 3.66E-04 | 12 | O15239, P13073, P05496, P05141, P12236, P63092, O75460, P18848, P43686, P62195, P0DP24, Q13557 | NDUFA1, COX4I1, ATP5G1, SLC25A5, SLC25A6, GNAS, ERN1, ATF4, PSMC4, PSMC5, CALM2, CAMK2D | More | | Irbesartan | hsa05014 | Amyotrophic lateral sclerosis | 4.61E-03 | 15 | O15399, P10415, P20333, O15239, P05496, P18848, Q13509, P68371, P43686, P62195, P51991, Q53GS7, P35658, P63261, Q9GZY0 | GRIN2D, BCL2, TNFRSF1B, NDUFA1, ATP5G1, ATF4, TUBB3, TUBB2C, PSMC4, PSMC5, HNRPA3, GLE1, NUP214, ACTG1, NXF2; NXF2B | More | | Irbesartan | hsa05016 | Huntington disease | 1.17E-04 | 13 | O95298, P13073, P12074, Q9GZM3, P24928, P30876, P62487, P52435, P05141, O75460, P28070, P55036, O00232 | NDUFC2, COX4I1, COX6A1, POLR2J2, POLR2A, POLR2B, POLR2G, POLR2J, SLC25A5, ERN1, PSMB4, PSMD4, PSMD12 | More | | Irbesartan | hsa05020 | Prion disease | 1.30E-04 | 19 | P01584, P46531, P11142, O15239, O14521, P05496, P12074, Q14643, P18848, P05141, P12236, P45880, P43686, P62195, Q13509, P68371, Q99941, P14598, Q15080 | IL1B, NOTCH1, HSPA8, NDUFA1, SDHD, ATP5G1, COX6A1, ITPR1, ATF4, SLC25A5, SLC25A6, VDAC2, PSMC4, PSMC5, TUBB3, TUBB2C, CREBL1, NCF1, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P01584 | IL1B | Interleukin-1 beta | 0.75 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.747 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P46531 | NOTCH1 | Neurogenic locus notch homolog protein 1 | 0.706 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P11142 | HSPA8 | Heat shock cognate 71 kDa protein | 0.766 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.747 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.728 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.718 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.733 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P12074 | COX6A1 | Cytochrome c oxidase subunit 6A1, mitochondrial | 0.754 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.701 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.781 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.725 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.722 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | P45880 | VDAC2 | Voltage-dependent anion-selective channel protein 2 | 0.708 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P62195 | PSMC5 | 26S proteasome regulatory subunit 8 | 0.721 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.716 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.892 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.802 | P49354 | FNTA | Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha | Q99941 | CREBL1 | Cyclic AMP-dependent transcription factor ATF-6 beta | 0.769 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.816 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.813 |
| Irbesartan | hsa05022 | Pathways of neurodegeneration - multiple diseases | 2.22E-04 | 22 | Q14643, Q13509, P68371, P10415, O15239, O14521, P13073, P05496, O75460, P18848, Q13561, P05141, P12236, P17252, P20333, O15169, P01584, P0DP24, P0DP23, Q13557, P43686, P62195 | ITPR1, TUBB3, TUBB2C, BCL2, NDUFA1, SDHD, COX4I1, ATP5G1, ERN1, ATF4, DCTN2, SLC25A5, SLC25A6, PRKCA, TNFRSF1B, AXIN1, IL1B, CALM2, CALM1, CAMK2D, PSMC4, PSMC5 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.701 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.716 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.892 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.848 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O15239 | NDUFA1 | NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 1 | 0.747 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | O14521 | SDHD | Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial | 0.728 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P13073 | COX4I1 | Cytochrome c oxidase subunit 4 isoform 1, mitochondrial | 0.717 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P05496 | ATP5G1 | ATP synthase F(0) complex subunit C1, mitochondrial | 0.718 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | O75460 | ERN1 | Serine/threonine-protein kinase/endoribonuclease IRE1 | 0.702 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.781 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P18848 | ATF4 | Cyclic AMP-dependent transcription factor ATF-4 | 0.723 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13561 | DCTN2 | Dynactin subunit 2 | -0.862 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.725 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P05141 | SLC25A5 | ADP/ATP translocase 2 | 0.797 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P12236 | SLC25A6 | ADP/ATP translocase 3 | 0.722 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P17252 | PRKCA | Protein kinase C alpha type | 0.849 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.772 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | 0.706 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | O15169 | AXIN1 | Axin-1 | 0.795 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P01584 | IL1B | Interleukin-1 beta | 0.825 | P61073 | CXCR4 | C-X-C chemokine receptor type 4 | P0DP24 | CALM2 | Calmodulin-2 | 0.759 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P0DP23 | CALM1 | Calmodulin-1 | -0.8 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | Q13557 | CAMK2D | Calcium/calmodulin-dependent protein kinase type II subunit delta | 0.749 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P43686 | PSMC4 | 26S proteasome regulatory subunit 6B | 0.835 | P40926 | MDH2 | Malate dehydrogenase, mitochondrial | P62195 | PSMC5 | 26S proteasome regulatory subunit 8 | 0.721 |
| Irbesartan | hsa05030 | Cocaine addiction | 2.63E-03 | 3 | P63092, Q99941, P18848 | GNAS, CREBL1, ATF4 | More | | Irbesartan | hsa05031 | Amphetamine addiction | 3.94E-06 | 8 | O15399, P0DP23, Q16566, Q13557, P63092, Q99941, P18848, P17252 | GRIN2D, CALM1, CAMK4, CAMK2D, GNAS, CREBL1, ATF4, PRKCA | More | | Irbesartan | hsa05032 | Morphine addiction | 2.47E-03 | 3 | P62873, P48169, P63092 | GNB1, GABRA4, GNAS | More | | Irbesartan | hsa05034 | Alcoholism | 1.13E-05 | 8 | Q13547, P63218, P50151, Q93077, P62807, Q16778, O60814, P68431 | HDAC1, GNG5, GNG10, HIST1H2AC, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12 | More | | Irbesartan | hsa05100 | Bacterial invasion of epithelial cells | 4.54E-02 | 3 | Q14141, Q05397, Q96JJ3 | SEPT6, PTK2, ELMO2 | More | | Irbesartan | hsa05110 | Vibrio cholerae infection | 2.11E-03 | 2 | Q99437, P17612 | ATP6V0B, PRKACA | More | | Irbesartan | hsa05120 | Epithelial cell signaling in Helicobacter pylori infection | 1.91E-04 | 7 | Q16539, Q99437, P09341, P10145, P25024, P25025, P07948 | MAPK14, ATP6V0B, CXCL1, IL8, CXCR1, CXCR2, LYN | More | | Irbesartan | hsa05130 | Pathogenic Escherichia coli infection | 7.39E-03 | 4 | Q14247, P56750, O00501, P25116 | CTTN, CLDN17, CLDN5, F2R | More | | Irbesartan | hsa05131 | Shigellosis | 2.93E-02 | 6 | Q9NQL2, P0CG47, Q14141, Q96JJ3, Q05397, Q13315 | RRAGD, UBB, SEPT6, ELMO2, PTK2, ATM | More | | Irbesartan | hsa05132 | Salmonella infection | 2.45E-08 | 13 | P51617, Q9UJU2, P63261, Q13546, Q13489, P10415, O75369, O60603, Q9BQS8, P51808, Q13561, Q13509, P68371 | IRAK1, LEF1, ACTG1, RIPK1, BIRC3, BCL2, FLNB, TLR2, FYCO1, DYNLT3, DCTN2, TUBB3, TUBB2C | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | P51684 | CCR6 | C-C chemokine receptor type 6 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.722 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | -0.72 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.808 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.908 | P46091 | GPR1 | Chemerin-like receptor 2 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.736 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.835 | P46091 | GPR1 | Chemerin-like receptor 2 | P63261 | ACTG1 | Actin, cytoplasmic 2 | 0.776 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.788 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.868 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | -0.788 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 1 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.848 | P46091 | GPR1 | Chemerin-like receptor 2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.759 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.848 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | P46091 | GPR1 | Chemerin-like receptor 2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.808 | P51684 | CCR6 | C-C chemokine receptor type 6 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.84 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O75369 | FLNB | Filamin-B | -0.762 | P51684 | CCR6 | C-C chemokine receptor type 6 | O75369 | FLNB | Filamin-B | -0.717 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | O60603 | TLR2 | Toll-like receptor 2 | -0.729 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | P51684 | CCR6 | C-C chemokine receptor type 6 | O60603 | TLR2 | Toll-like receptor 2 | -0.767 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.929 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q9BQS8 | FYCO1 | FYVE and coiled-coil domain-containing protein 1 | 0.721 | P51684 | CCR6 | C-C chemokine receptor type 6 | P51808 | DYNLT3 | Dynein light chain Tctex-type 3 | 0.731 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13561 | DCTN2 | Dynactin subunit 2 | 0.754 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13561 | DCTN2 | Dynactin subunit 2 | -0.862 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13561 | DCTN2 | Dynactin subunit 2 | -0.843 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13561 | DCTN2 | Dynactin subunit 2 | -0.781 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | Q13509 | TUBB3 | Tubulin beta-3 chain | 0.735 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.716 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.809 | P46091 | GPR1 | Chemerin-like receptor 2 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.748 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13509 | TUBB3 | Tubulin beta-3 chain | -0.835 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | P68371 | TUBB2C | Tubulin beta-4B chain | 0.748 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.892 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.766 | P46091 | GPR1 | Chemerin-like receptor 2 | P68371 | TUBB2C | Tubulin beta-4B chain | -0.751 |
| Irbesartan | hsa05133 | Pertussis | 8.18E-08 | 7 | P11215, P05107, P0DP23, P23528, P09871, P0C0L4, Q02556 | ITGAM, ITGB2, CALM1, CFL1, C1S, C4A, IRF8 | More | | Irbesartan | hsa05134 | Legionellosis | 2.82E-02 | 3 | P01584, Q9NR31, P0DMV8 | IL1B, SAR1A, HSPA1A | More | | Irbesartan | hsa05135 | Yersinia infection | 4.65E-02 | 5 | P13612, P06239, Q16539, P01375, P49841 | ITGA4, LCK, MAPK14, TNF, GSK3B | More | | Irbesartan | hsa05140 | Leishmaniasis | 2.05E-08 | 15 | P13612, O75015, P14598, P23458, P42224, P13765, O60603, P25963, P01375, P01584, P29350, P49006, Q16539, P51617, Q15080 | ITGA4, FCGR3B, NCF1, JAK1, STAT1, HLA-DOB, TLR2, NFKBIA, TNF, IL1B, PTPN6, MARCKSL1, MAPK14, IRAK1, NCF4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13612 | ITGA4 | Integrin alpha-4 | -0.797 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13612 | ITGA4 | Integrin alpha-4 | 0.774 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.92 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | 0.814 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O75015 | FCGR3B | Low affinity immunoglobulin gamma Fc region receptor III-B | -0.778 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.798 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.721 | P51684 | CCR6 | C-C chemokine receptor type 6 | P14598 | NCF1 | Neutrophil cytosol factor 1 | -0.713 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.787 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.785 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | -0.754 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.85 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | P49336 | CDK8 | Cyclin-dependent kinase 8 | O60603 | TLR2 | Toll-like receptor 2 | -0.734 | P51684 | CCR6 | C-C chemokine receptor type 6 | O60603 | TLR2 | Toll-like receptor 2 | -0.767 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | 0.768 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P25963 | NFKBIA | NF-kappa-B inhibitor alpha | -0.728 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P09960 | LTA4H | Leukotriene A-4 hydrolase | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | 0.808 | P49336 | CDK8 | Cyclin-dependent kinase 8 | P29350 | PTPN6 | Tyrosine-protein phosphatase non-receptor type 6 | -0.726 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49006 | MARCKSL1 | MARCKS-related protein | -0.852 | P51684 | CCR6 | C-C chemokine receptor type 6 | P49006 | MARCKSL1 | MARCKS-related protein | 0.727 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P51684 | CCR6 | C-C chemokine receptor type 6 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.722 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.762 | P09960 | LTA4H | Leukotriene A-4 hydrolase | Q15080 | NCF4 | Neutrophil cytosol factor 4 | 0.758 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.74 | P49336 | CDK8 | Cyclin-dependent kinase 8 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.754 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q15080 | NCF4 | Neutrophil cytosol factor 4 | -0.803 |
| Irbesartan | hsa05143 | African trypanosomiasis | 5.26E-06 | 4 | P01375, P69905, P68871, P48023 | TNF, HBA2, HBB, FASLG | More | | Irbesartan | hsa05144 | Malaria | 6.64E-08 | 9 | P60033, P69905, P68871, O60603, P01375, P35443, P01584, P10145, P26718 | CD81, HBA2, HBB, TLR2, TNF, THBS4, IL1B, IL8, KLRK1 | More | | Irbesartan | hsa05145 | Toxoplasmosis | 3.96E-02 | 2 | P28068, Q16787 | HLA-DMB, LAMA3 | More | | Irbesartan | hsa05146 | Amoebiasis | 2.21E-08 | 11 | P01584, Q13751, P09341, P14778, P27930, P01375, O60603, P05089, P22694, P12814, P08311 | IL1B, LAMB3, CXCL1, IL1R1, IL1R2, TNF, TLR2, ARG1, PRKACB, ACTN1, CTSG | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01584 | IL1B | Interleukin-1 beta | 0.807 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | Q13751 | LAMB3 | Laminin subunit beta-3 | -0.763 | Q04759 | PRKCQ | Protein kinase C theta type | P09341 | CXCL1 | Growth-regulated alpha protein | -0.885 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09341 | CXCL1 | Growth-regulated alpha protein | 0.788 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09341 | CXCL1 | Growth-regulated alpha protein | 0.7 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P09341 | CXCL1 | Growth-regulated alpha protein | -0.802 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.796 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P09341 | CXCL1 | Growth-regulated alpha protein | -0.839 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.766 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.807 | Q04759 | PRKCQ | Protein kinase C theta type | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.733 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.811 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.726 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P01375 | TNF | Tumor necrosis factor | 0.78 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P01375 | TNF | Tumor necrosis factor | -0.79 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | O60603 | TLR2 | Toll-like receptor 2 | -0.714 | Q04759 | PRKCQ | Protein kinase C theta type | P05089 | ARG1 | Arginase-1 | -0.899 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05089 | ARG1 | Arginase-1 | 0.848 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P05089 | ARG1 | Arginase-1 | 0.702 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P05089 | ARG1 | Arginase-1 | -0.868 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P05089 | ARG1 | Arginase-1 | -0.703 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P05089 | ARG1 | Arginase-1 | -0.793 | Q04759 | PRKCQ | Protein kinase C theta type | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.755 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | -0.772 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P22694 | PRKACB | cAMP-dependent protein kinase catalytic subunit beta | 0.873 | Q04759 | PRKCQ | Protein kinase C theta type | P12814 | ACTN1 | Alpha-actinin-1 | -0.821 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P12814 | ACTN1 | Alpha-actinin-1 | -0.8 | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | P12814 | ACTN1 | Alpha-actinin-1 | -0.814 | Q04759 | PRKCQ | Protein kinase C theta type | P08311 | CTSG | Cathepsin G | -0.913 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08311 | CTSG | Cathepsin G | 0.744 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P08311 | CTSG | Cathepsin G | -0.866 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P08311 | CTSG | Cathepsin G | -0.733 |
| Irbesartan | hsa05152 | Tuberculosis | 8.64E-05 | 9 | Q13488, P0DP23, P48382, O60603, P10415, P13765, P01568, Q9UDY8, P51617 | TCIRG1, CALM1, RFX5, TLR2, BCL2, HLA-DOB, IFNA21, MALT1, IRAK1 | More | | Irbesartan | hsa05160 | Hepatitis C | 1.16E-03 | 6 | P52630, P60033, Q9NZJ5, P49841, P01375, P48023 | STAT2, CD81, EIF2AK3, GSK3B, TNF, FASLG | More | | Irbesartan | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | | Irbesartan | hsa05162 | Measles | 3.18E-02 | 4 | P23458, P0DMV8, P01584, Q9NP90 | JAK1, HSPA1A, IL1B, RAB9B | More | | Irbesartan | hsa05163 | Human cytomegalovirus infection | 4.52E-07 | 24 | P01375, P62873, P63218, P50151, Q14643, P0DP23, P61586, Q8NHW4, Q08828, P51828, P23458, P49841, P14778, P01584, P17252, Q13651, P25025, Q16539, P63092, P04637, Q13546, O00463, P61769, P01568 | TNF, GNB1, GNG5, GNG10, ITPR1, CALM1, RHOA, CCL4L2, ADCY1, ADCY7, JAK1, GSK3B, IL1R1, IL1B, PRKCA, IL10RA, CXCR2, MAPK14, GNAS, TP53, RIPK1, TRAF5, B2M, IFNA21 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P01375 | TNF | Tumor necrosis factor | 0.718 | P48169 | GABRA4 | Gamma-aminobutyric acid receptor subunit alpha-4 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.736 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.795 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.727 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.743 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | -0.728 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.701 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P0DP23 | CALM1 | Calmodulin-1 | 0.822 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P0DP23 | CALM1 | Calmodulin-1 | -0.8 | P48169 | GABRA4 | Gamma-aminobutyric acid receptor subunit alpha-4 | P61586 | RHOA | Transforming protein RhoA | -0.769 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q8NHW4 | CCL4L2 | C-C motif chemokine 4-like | 0.802 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q08828 | ADCY1 | Adenylate cyclase type 1 | 0.84 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P51828 | ADCY7 | Adenylate cyclase type 7 | 0.834 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.78 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 1 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | 0.823 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.857 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | P01584 | IL1B | Interleukin-1 beta | 0.799 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P17252 | PRKCA | Protein kinase C alpha type | 0.849 | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | Q13651 | IL10RA | Interleukin-10 receptor subunit alpha | 0.799 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.889 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.861 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P25025 | CXCR2 | C-X-C chemokine receptor type 2 | 0.929 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.795 | P48169 | GABRA4 | Gamma-aminobutyric acid receptor subunit alpha-4 | P63092 | GNAS | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | -0.709 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.788 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.837 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.734 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | O00463 | TRAF5 | TNF receptor-associated factor 5 | -0.788 | P48169 | GABRA4 | Gamma-aminobutyric acid receptor subunit alpha-4 | P61769 | B2M | Beta-2-microglobulin | -0.711 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P01568 | IFNA21 | Interferon alpha-21 | 0.898 |
| Irbesartan | hsa05165 | Human papillomavirus infection | 2.01E-02 | 3 | Q16787, Q02930, Q13315 | LAMA3, CREB5, ATM | More | | Irbesartan | hsa05166 | Human T-cell leukemia virus 1 infection | 2.91E-02 | 3 | Q02930, P28068, Q13315 | CREB5, HLA-DMB, ATM | More | | Irbesartan | hsa05167 | Kaposi sarcoma-associated herpesvirus infection | 1.94E-02 | 4 | P62879, P16298, Q02750, P0CG47 | GNB2, PPP3CB, MAP2K1, UBB | More | | Irbesartan | hsa05168 | Herpes simplex virus 1 infection | 1.04E-05 | 18 | Q9UKJ0, P25963, P01568, Q05823, Q9GZY0, P42224, Q07955, Q01130, Q13243, Q13489, P42338, Q13398, Q9HCX3, Q03923, P52738, O75820, Q9UDV6, P10415 | PILRB, NFKBIA, IFNA21, RNASEL, NXF2; NXF2B, STAT1, SFRS1, SFRS2, SFRS5, BIRC3, PIK3CB, ZNF211, ZNF304, ZNF85, ZNF140, ZNF189, ZNF212, BCL2 | More | | Irbesartan | hsa05169 | Epstein-Barr virus infection | 4.60E-06 | 20 | P13765, Q13547, Q92769, P04637, Q13546, O00463, P10415, P42338, P07948, Q13761, P24522, O75293, P48551, P01375, O60603, P29728, P51617, P07766, P09693, P20963 | HLA-DOB, HDAC1, HDAC2, TP53, RIPK1, TRAF5, BCL2, PIK3CB, LYN, RUNX3, GADD45A, GADD45B, IFNAR2, TNF, TLR2, OAS2, IRAK1, CD3E, CD3G, CD247 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.82 | P32249 | GPR183 | G-protein coupled receptor 183 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.845 | P32248 | CCR7 | C-C chemokine receptor type 7 | P13765 | HLA-DOB | HLA class II histocompatibility antigen, DO beta chain | 0.808 | Q04759 | PRKCQ | Protein kinase C theta type | Q13547 | HDAC1 | Histone deacetylase 1 | 0.723 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q13547 | HDAC1 | Histone deacetylase 1 | -0.774 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q92769 | HDAC2 | Histone deacetylase 2 | 0.702 | P32249 | GPR183 | G-protein coupled receptor 183 | P04637 | TP53 | Cellular tumor antigen p53 | 0.711 | P32248 | CCR7 | C-C chemokine receptor type 7 | P04637 | TP53 | Cellular tumor antigen p53 | 0.77 | P51684 | CCR6 | C-C chemokine receptor type 6 | P04637 | TP53 | Cellular tumor antigen p53 | 0.728 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.868 | Q04759 | PRKCQ | Protein kinase C theta type | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.81 | P32249 | GPR183 | G-protein coupled receptor 183 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.719 | P32248 | CCR7 | C-C chemokine receptor type 7 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.748 | P51684 | CCR6 | C-C chemokine receptor type 6 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.84 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 1 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P07948 | LYN | Tyrosine-protein kinase Lyn | 0.735 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Q13761 | RUNX3 | Runt-related transcription factor 3 | -0.708 | Q04759 | PRKCQ | Protein kinase C theta type | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.846 | P32249 | GPR183 | G-protein coupled receptor 183 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.925 | P32248 | CCR7 | C-C chemokine receptor type 7 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.862 | P51684 | CCR6 | C-C chemokine receptor type 6 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.712 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.768 | P32249 | GPR183 | G-protein coupled receptor 183 | P48551 | IFNAR2 | Interferon alpha/beta receptor 2 | 0.714 | Q04759 | PRKCQ | Protein kinase C theta type | P01375 | TNF | Tumor necrosis factor | -0.725 | P51684 | CCR6 | C-C chemokine receptor type 6 | O60603 | TLR2 | Toll-like receptor 2 | -0.767 | Q04759 | PRKCQ | Protein kinase C theta type | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | 0.875 | P32249 | GPR183 | G-protein coupled receptor 183 | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | 0.705 | P32248 | CCR7 | C-C chemokine receptor type 7 | P29728 | OAS2 | 2'-5'-oligoadenylate synthase 2 | 0.738 | P51684 | CCR6 | C-C chemokine receptor type 6 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.722 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.77 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P32249 | GPR183 | G-protein coupled receptor 183 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.864 | P32248 | CCR7 | C-C chemokine receptor type 7 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.864 | P51684 | CCR6 | C-C chemokine receptor type 6 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.753 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 |
| Irbesartan | hsa05170 | Human immunodeficiency virus 1 infection | 1.97E-09 | 20 | Q02750, P62873, P62879, P16298, P0DP23, Q05397, P17252, Q13546, O00463, Q14643, P01568, P51617, O60603, Q13315, P23528, P09693, P10415, Q93034, Q9Y6Q5, P20333 | MAP2K1, GNB1, GNB2, PPP3CB, CALM1, PTK2, PRKCA, RIPK1, TRAF5, ITPR1, IFNA21, IRAK1, TLR2, ATM, CFL1, CD3G, BCL2, CUL5, AP1M2, TNFRSF1B | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.93 | P11511 | CYP19A1 | Aromatase | Q02750 | MAP2K1 | Dual specificity mitogen-activated protein kinase kinase 1 | 0.783 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.795 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P62873 | GNB1 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-1 | -0.777 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.96 | P11511 | CYP19A1 | Aromatase | P62879 | GNB2 | Guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2 | 0.704 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.93 | P11511 | CYP19A1 | Aromatase | P16298 | PPP3CB | Serine/threonine-protein phosphatase 2B catalytic subunit beta isoform | 0.706 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P0DP23 | CALM1 | Calmodulin-1 | -0.8 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P0DP23 | CALM1 | Calmodulin-1 | -0.772 | P51684 | CCR6 | C-C chemokine receptor type 6 | P0DP23 | CALM1 | Calmodulin-1 | -0.734 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q05397 | PTK2 | Focal adhesion kinase 1 | 0.932 | P11511 | CYP19A1 | Aromatase | Q05397 | PTK2 | Focal adhesion kinase 1 | 0.75 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P17252 | PRKCA | Protein kinase C alpha type | 0.849 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P17252 | PRKCA | Protein kinase C alpha type | 0.844 | P51684 | CCR6 | C-C chemokine receptor type 6 | P17252 | PRKCA | Protein kinase C alpha type | 0.738 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.788 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q13546 | RIPK1 | Receptor-interacting serine/threonine-protein kinase 1 | -0.868 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O00463 | TRAF5 | TNF receptor-associated factor 5 | 0.773 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.701 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.858 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q14643 | ITPR1 | Inositol 1,4,5-trisphosphate receptor type 1 | 0.81 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P01568 | IFNA21 | Interferon alpha-21 | 0.898 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P01568 | IFNA21 | Interferon alpha-21 | 0.721 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.807 | P51684 | CCR6 | C-C chemokine receptor type 6 | P51617 | IRAK1 | Interleukin-1 receptor-associated kinase 1 | 0.722 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | O60603 | TLR2 | Toll-like receptor 2 | -0.729 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | O60603 | TLR2 | Toll-like receptor 2 | -0.884 | P51684 | CCR6 | C-C chemokine receptor type 6 | O60603 | TLR2 | Toll-like receptor 2 | -0.767 | P51812 | RPS6KA3 | Ribosomal protein S6 kinase alpha-3 | Q13315 | ATM | Serine-protein kinase ATM | -0.748 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P23528 | CFL1 | Cofilin-1 | 0.787 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P23528 | CFL1 | Cofilin-1 | 0.741 | P51684 | CCR6 | C-C chemokine receptor type 6 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.753 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.848 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 1 | P51684 | CCR6 | C-C chemokine receptor type 6 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.84 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q93034 | CUL5 | Cullin-5 | 0.704 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.75 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.901 | P51684 | CCR6 | C-C chemokine receptor type 6 | Q9Y6Q5 | AP1M2 | AP-1 complex subunit mu-2 | -0.86 | P11511 | CYP19A1 | Aromatase | P20333 | TNFRSF1B | Tumor necrosis factor receptor superfamily member 1B | -0.75 |
| Irbesartan | hsa05200 | Pathways in cancer | 1.36E-05 | 34 | Q13751, P42338, P08238, P42224, P19174, P04637, Q9UJU2, P17252, Q09472, P43246, P84022, Q13485, Q13547, P14923, P30281, P10415, Q13489, Q13077, P49767, P43657, P25116, P63218, P50151, Q14344, O95267, Q7LDG7, P78417, P24522, O75293, P0DP23, P01568, P14784, P40189, P16871 | LAMB3, PIK3CB, HSP90AB1, STAT1, PLCG1, TP53, LEF1, PRKCA, EP300, MSH2, SMAD3, SMAD4, HDAC1, JUP, CCND3, BCL2, BIRC3, TRAF1, VEGFC, P2RY5, F2R, GNG5, GNG10, GNA13, RASGRP1, RASGRP2, GSTO1, GADD45A, GADD45B, CALM1, IFNA21, IL2RB, IL6ST, IL7R | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13751 | LAMB3 | Laminin subunit beta-3 | 0.844 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0.777 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | -0.823 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.764 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | -0.766 | P32248 | CCR7 | C-C chemokine receptor type 7 | P04637 | TP53 | Cellular tumor antigen p53 | 0.77 | P46091 | GPR1 | Chemerin-like receptor 2 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.736 | P32248 | CCR7 | C-C chemokine receptor type 7 | Q9UJU2 | LEF1 | Lymphoid enhancer-binding factor 1 | 0.813 | P46091 | GPR1 | Chemerin-like receptor 2 | P17252 | PRKCA | Protein kinase C alpha type | 0.741 | P32248 | CCR7 | C-C chemokine receptor type 7 | Q09472 | EP300 | Histone acetyltransferase p300 | -0.791 | P29375 | JARID1A | Lysine-specific demethylase 5A | P43246 | MSH2 | DNA mismatch repair protein Msh2 | 0.87 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.811 | P46091 | GPR1 | Chemerin-like receptor 2 | P43246 | MSH2 | DNA mismatch repair protein Msh2 | -0.838 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P84022 | SMAD3 | Mothers against decapentaplegic homolog 3 | 0.725 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.746 | P46091 | GPR1 | Chemerin-like receptor 2 | Q13485 | SMAD4 | Mothers against decapentaplegic homolog 4 | -0.809 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.754 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14923 | JUP | Junction plakoglobin | -0.735 | P46091 | GPR1 | Chemerin-like receptor 2 | P14923 | JUP | Junction plakoglobin | 0.883 | P32248 | CCR7 | C-C chemokine receptor type 7 | P14923 | JUP | Junction plakoglobin | 0.711 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P30281 | CCND3 | G1/S-specific cyclin-D3 | 0.743 | P46091 | GPR1 | Chemerin-like receptor 2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.808 | P32248 | CCR7 | C-C chemokine receptor type 7 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.748 | P46091 | GPR1 | Chemerin-like receptor 2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.759 | P32248 | CCR7 | C-C chemokine receptor type 7 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P49767 | VEGFC | Vascular endothelial growth factor C | 0.743 | P46091 | GPR1 | Chemerin-like receptor 2 | P49767 | VEGFC | Vascular endothelial growth factor C | 0.718 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P43657 | P2RY5 | Lysophosphatidic acid receptor 6 | -0.735 | P46091 | GPR1 | Chemerin-like receptor 2 | P25116 | F2R | Proteinase-activated receptor 1 | 0.76 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P63218 | GNG5 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-5 | 0.941 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P50151 | GNG10 | Guanine nucleotide-binding protein G(I)/G(S)/G(O) subunit gamma-10 | 0.948 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q14344 | GNA13 | Guanine nucleotide-binding protein subunit alpha-13 | 0.87 | P32248 | CCR7 | C-C chemokine receptor type 7 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.792 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | Q7LDG7 | RASGRP2 | RAS guanyl-releasing protein 2 | 0.704 | P46091 | GPR1 | Chemerin-like receptor 2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.738 | P32248 | CCR7 | C-C chemokine receptor type 7 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.862 | P29375 | JARID1A | Lysine-specific demethylase 5A | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | -0.748 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | O75293 | GADD45B | Growth arrest and DNA damage-inducible protein GADD45 beta | 0.731 | P29375 | JARID1A | Lysine-specific demethylase 5A | P0DP23 | CALM1 | Calmodulin-1 | 0.755 | P46091 | GPR1 | Chemerin-like receptor 2 | P0DP23 | CALM1 | Calmodulin-1 | -0.846 | P46091 | GPR1 | Chemerin-like receptor 2 | P01568 | IFNA21 | Interferon alpha-21 | 0.724 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14784 | IL2RB | Interleukin-2 receptor subunit beta | 0.768 | P09917 | ALOX5 | Polyunsaturated fatty acid 5-lipoxygenase | P14784 | IL2RB | Interleukin-2 receptor subunit beta | -0.835 | P29375 | JARID1A | Lysine-specific demethylase 5A | P40189 | IL6ST | Interleukin-6 receptor subunit beta | 0.83 | P32248 | CCR7 | C-C chemokine receptor type 7 | P16871 | IL7R | Interleukin-7 receptor subunit alpha | 0.743 |
| Irbesartan | hsa05202 | Transcriptional misregulation in cancer | 8.16E-08 | 27 | Q92570, Q12778, Q15532, Q13315, O94812, P58340, P10145, P17844, P14780, P27930, P14923, Q15744, Q16548, Q13489, Q13077, O15550, P04637, P35226, P05164, P12838, P08246, Q9C0K0, P41182, Q13547, Q92769, P12980, P24522 | NR4A3, FOXO1, SS18, ATM, BAIAP3, MLF1, IL8, DDX5, MMP9, IL1R2, JUP, CEBPE, BCL2A1, BIRC3, TRAF1, UTX, TP53, BMI1, MPO, DEFA4, ELA2, BCL11B, BCL6, HDAC1, HDAC2, LYL1, GADD45A | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | Q92570 | NR4A3 | Nuclear receptor subfamily 4 group A member 3 | -0.754 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q12778 | FOXO1 | Forkhead box protein O1 | 0.794 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q15532 | SS18 | Protein SSXT | 0.877 | P32248 | CCR7 | C-C chemokine receptor type 7 | Q15532 | SS18 | Protein SSXT | 0.804 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13315 | ATM | Serine-protein kinase ATM | 0.752 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | O94812 | BAIAP3 | BAI1-associated protein 3 | 0.73 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | P58340 | MLF1 | Myeloid leukemia factor 1 | 0.7 | P38919 | EIF4A3 | Eukaryotic initiation factor 4A-III | P10145 | IL8 | Interleukin-8 | 0.941 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P17844 | DDX5 | Probable ATP-dependent RNA helicase DDX5 | 0.863 | Q04759 | PRKCQ | Protein kinase C theta type | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.787 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.94 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.855 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14780 | MMP9 | Matrix metalloproteinase-9 | -0.765 | Q04759 | PRKCQ | Protein kinase C theta type | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.733 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.926 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.727 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P14923 | JUP | Junction plakoglobin | 0.861 | P32248 | CCR7 | C-C chemokine receptor type 7 | P14923 | JUP | Junction plakoglobin | 0.711 | Q04759 | PRKCQ | Protein kinase C theta type | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.745 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q15744 | CEBPE | CCAAT/enhancer-binding protein epsilon | -0.833 | Q04759 | PRKCQ | Protein kinase C theta type | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.76 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16548 | BCL2A1 | Bcl-2-related protein A1 | 0.958 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.877 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q16548 | BCL2A1 | Bcl-2-related protein A1 | -0.746 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13489 | BIRC3 | Baculoviral IAP repeat-containing protein 3 | 0.848 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13077 | TRAF1 | TNF receptor-associated factor 1 | -0.796 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.83 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.816 | P32248 | CCR7 | C-C chemokine receptor type 7 | Q13077 | TRAF1 | TNF receptor-associated factor 1 | 0.748 | P32248 | CCR7 | C-C chemokine receptor type 7 | O15550 | UTX | Lysine-specific demethylase 6A | -0.715 | P32248 | CCR7 | C-C chemokine receptor type 7 | P04637 | TP53 | Cellular tumor antigen p53 | 0.77 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P35226 | BMI1 | Polycomb complex protein BMI-1 | -0.778 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.76 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P35226 | BMI1 | Polycomb complex protein BMI-1 | 0.78 | Q04759 | PRKCQ | Protein kinase C theta type | P05164 | MPO | Myeloperoxidase | -0.88 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P05164 | MPO | Myeloperoxidase | 0.719 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P05164 | MPO | Myeloperoxidase | -0.811 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P05164 | MPO | Myeloperoxidase | -0.81 | Q04759 | PRKCQ | Protein kinase C theta type | P12838 | DEFA4 | Neutrophil defensin 4 | -0.833 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P12838 | DEFA4 | Neutrophil defensin 4 | 0.784 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P12838 | DEFA4 | Neutrophil defensin 4 | -0.86 | Q04759 | PRKCQ | Protein kinase C theta type | P08246 | ELA2 | Neutrophil elastase | -0.748 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P08246 | ELA2 | Neutrophil elastase | 0.702 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P08246 | ELA2 | Neutrophil elastase | -0.782 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | P08246 | ELA2 | Neutrophil elastase | -0.942 | Q04759 | PRKCQ | Protein kinase C theta type | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.774 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | -0.783 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.9 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.766 | P32248 | CCR7 | C-C chemokine receptor type 7 | Q9C0K0 | BCL11B | B-cell lymphoma/leukemia 11B | 0.72 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P41182 | BCL6 | B-cell lymphoma 6 protein | 0.919 | Q04759 | PRKCQ | Protein kinase C theta type | Q13547 | HDAC1 | Histone deacetylase 1 | 0.723 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q13547 | HDAC1 | Histone deacetylase 1 | -0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q92769 | HDAC2 | Histone deacetylase 2 | -0.7 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P12980 | LYL1 | Protein lyl-1 | 0.784 | Q04759 | PRKCQ | Protein kinase C theta type | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.846 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | 0.819 | Q08881 | ITK | Tyrosine-protein kinase ITK/TSK | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.75 | P32248 | CCR7 | C-C chemokine receptor type 7 | P24522 | GADD45A | Growth arrest and DNA damage-inducible protein GADD45 alpha | -0.862 |
| Irbesartan | hsa05203 | Viral carcinogenesis | 5.69E-07 | 14 | Q12933, Q99941, P18848, P06746, P07948, P27348, Q13547, Q15283, P61586, P12814, P61978, P62807, Q16778, O60814 | TRAF2, CREBL1, ATF4, POLB, LYN, YWHAQ, HDAC1, RASA2, RHOA, ACTN1, HNRPK, HIST1H2BC, HIST2H2BE, H2BC12 | More | | Irbesartan | hsa05204 | Chemical carcinogenesis | 1.48E-02 | 2 | P78417, P11712 | GSTO1, CYP2C9 | More | | Irbesartan | hsa05205 | Proteoglycans in cancer | 1.09E-02 | 10 | Q13009, Q12955, Q14643, O75369, P14780, P17252, O60603, P04628, Q13635, P08962 | TIAM1, ANK3, ITPR1, FLNB, MMP9, PRKCA, TLR2, WNT1, PTCH1, CD63 | More | | Irbesartan | hsa05206 | MicroRNAs in cancer | 1.62E-04 | 7 | P15311, P21860, P61978, P46531, P63279, P22105, P61586 | VIL2, ERBB3, HNRPK, NOTCH1, UBE2I, TNXB, RHOA | More | | Irbesartan | hsa05210 | Colorectal cancer | 2.41E-02 | 4 | P10415, P04637, Q9UJU2, P24522 | BCL2, TP53, LEF1, GADD45A | More | | Irbesartan | hsa05212 | Pancreatic cancer | 4.96E-04 | 6 | P42338, P42224, P37173, P84022, Q13485, O75293 | PIK3CB, STAT1, TGFBR2, SMAD3, SMAD4, GADD45B | More | | Irbesartan | hsa05213 | Endometrial cancer | 1.98E-04 | 5 | O15169, Q9UJU2, Q02750, P04637, P24522 | AXIN1, LEF1, MAP2K1, TP53, GADD45A | More | | Irbesartan | hsa05214 | Glioma | 5.64E-06 | 7 | P0DP23, Q16566, P17252, P42338, P04637, P24522, O75293 | CALM1, CAMK4, PRKCA, PIK3CB, TP53, GADD45A, GADD45B | More | | Irbesartan | hsa05215 | Prostate cancer | 1.94E-02 | 4 | P10415, Q9UJU2, Q09472, P04637 | BCL2, LEF1, EP300, TP53 | More | | Irbesartan | hsa05216 | Thyroid cancer | 8.01E-07 | 5 | P01106, Q9UJU2, P04637, P24522, O75293 | MYC, LEF1, TP53, GADD45A, GADD45B | More | | Irbesartan | hsa05217 | Basal cell carcinoma | 8.10E-07 | 6 | Q13635, P04628, P49841, Q9UJU2, P04637, P24522 | PTCH1, WNT1, GSK3B, LEF1, TP53, GADD45A | More | | Irbesartan | hsa05219 | Bladder cancer | 4.07E-02 | 2 | P14780, P04637 | MMP9, TP53 | More | | Irbesartan | hsa05220 | Chronic myeloid leukemia | 2.16E-02 | 5 | Q13547, Q13485, P84022, P42338, O75293 | HDAC1, SMAD4, SMAD3, PIK3CB, GADD45B | More | | Irbesartan | hsa05222 | Small cell lung cancer | 1.94E-02 | 4 | P10415, Q13077, P04637, P24522 | BCL2, TRAF1, TP53, GADD45A | More | | Irbesartan | hsa05223 | Non-small cell lung cancer | 1.39E-02 | 3 | P10826, Q9HC35, O75293 | RARB, EML4, GADD45B | More | | Irbesartan | hsa05224 | Breast cancer | 5.34E-03 | 5 | Q9UJU2, P49841, Q92837, P04637, P24522 | LEF1, GSK3B, FRAT1, TP53, GADD45A | More | | Irbesartan | hsa05225 | Hepatocellular carcinoma | 1.85E-02 | 2 | Q92529, P51531 | SHC3, SMARCA2 | More | | Irbesartan | hsa05226 | Gastric cancer | 7.56E-05 | 7 | Q02750, Q9UJU2, O15169, P04637, P24522, P14923, P10415 | MAP2K1, LEF1, AXIN1, TP53, GADD45A, JUP, BCL2 | More | | Irbesartan | hsa05230 | Central carbon metabolism in cancer | 4.04E-02 | 2 | P07195, P04637 | LDHB, TP53 | More | | Irbesartan | hsa05231 | Choline metabolism in cancer | 3.79E-02 | 4 | O15245, P35790, Q9Y259, P19174 | SLC22A1, CHKA, CHKB, PLCG1 | More | | Irbesartan | hsa05235 | PD-L1 expression and PD-1 checkpoint pathway in cancer | 2.82E-08 | 14 | O95267, P19174, P07766, P20963, P09693, P06239, P23458, P42224, O60603, Q04759, Q16539, P19784, Q9HC35, P01730 | RASGRP1, PLCG1, CD3E, CD247, CD3G, LCK, JAK1, STAT1, TLR2, PRKCQ, MAPK14, CSNK2A2, EML4, CD4 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q04759 | PRKCQ | Protein kinase C theta type | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.733 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.852 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | -0.716 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | O95267 | RASGRP1 | RAS guanyl-releasing protein 1 | 0.737 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P19174 | PLCG1 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | 0.804 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.805 | Q04759 | PRKCQ | Protein kinase C theta type | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | 0.713 | P52732 | KIF11 | Kinesin-like protein KIF11 | P07766 | CD3E | T-cell surface glycoprotein CD3 epsilon chain | -0.724 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.769 | Q04759 | PRKCQ | Protein kinase C theta type | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.92 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | -0.786 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P20963 | CD247 | T-cell surface glycoprotein CD3 zeta chain | 0.797 | Q04759 | PRKCQ | Protein kinase C theta type | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.756 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.835 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | -0.744 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P09693 | CD3G | T-cell surface glycoprotein CD3 gamma chain | 0.812 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P06239 | LCK | Tyrosine-protein kinase Lck | 0.791 | Q04759 | PRKCQ | Protein kinase C theta type | P06239 | LCK | Tyrosine-protein kinase Lck | 0.779 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P06239 | LCK | Tyrosine-protein kinase Lck | -0.726 | P52732 | KIF11 | Kinesin-like protein KIF11 | P06239 | LCK | Tyrosine-protein kinase Lck | -0.721 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P06239 | LCK | Tyrosine-protein kinase Lck | 0.771 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | P23458 | JAK1 | Tyrosine-protein kinase JAK1 | 0.757 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P42224 | STAT1 | Signal transducer and activator of transcription 1-alpha/beta | 0.762 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | O60603 | TLR2 | Toll-like receptor 2 | 0.842 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | O60603 | TLR2 | Toll-like receptor 2 | 0.73 | Q04759 | PRKCQ | Protein kinase C theta type | Q04759 | PRKCQ | Protein kinase C theta type | 1 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q04759 | PRKCQ | Protein kinase C theta type | -0.767 | P00352 | ALDH1A1 | Aldehyde dehydrogenase 1A1 | Q04759 | PRKCQ | Protein kinase C theta type | 0.734 | P43490 | PBEF1 | Nicotinamide phosphoribosyltransferase | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.883 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | O75643 | ASCC3L1 | U5 small nuclear ribonucleoprotein 200 kDa helicase | P19784 | CSNK2A2 | Casein kinase II subunit alpha' | 0.82 | P52732 | KIF11 | Kinesin-like protein KIF11 | Q9HC35 | EML4 | Echinoderm microtubule-associated protein-like 4 | 0.794 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.707 | P52732 | KIF11 | Kinesin-like protein KIF11 | P01730 | CD4 | T-cell surface glycoprotein CD4 | -0.719 |
| Irbesartan | hsa05310 | Asthma | 2.79E-04 | 3 | P13765, P12724, P01375 | HLA-DOB, RNASE3, TNF | More | | Irbesartan | hsa05320 | Autoimmune thyroid disease | 8.64E-03 | 4 | P13765, P29965, P01568, P10747 | HLA-DOB, CD40LG, IFNA21, CD28 | More | | Irbesartan | hsa05321 | Inflammatory bowel disease | 2.41E-08 | 8 | O60603, P01375, P13765, Q14765, Q9UL17, P23771, P01584, Q9HBE5 | TLR2, TNF, HLA-DOB, STAT4, TBX21, GATA3, IL1B, IL21R | More | | Irbesartan | hsa05322 | Systemic lupus erythematosus | 1.69E-08 | 9 | P08311, P0C0L4, P09871, Q93077, P62807, Q16778, O60814, P68431, P12814 | CTSG, C4A, C1S, HIST1H2AC, HIST1H2BC, HIST2H2BE, H2BC12, H3C1; H3C2; H3C3; H3C4; H3C6; H3C7; H3C8; H3C10; H3C11; H3C12, ACTN1 | More | | Irbesartan | hsa05330 | Allograft rejection | 2.72E-02 | 2 | P48023, P01375 | FASLG, TNF | More | | Irbesartan | hsa05332 | Graft-versus-host disease | 5.02E-05 | 5 | P13765, P48023, P01375, P26715, Q13241 | HLA-DOB, FASLG, TNF, KLRC1, KLRD1 | More | | Irbesartan | hsa05340 | Primary immunodeficiency | 1.28E-03 | 4 | P01730, P11912, P07766, P06239 | CD4, CD79A, CD3E, LCK | More | | Irbesartan | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | | Irbesartan | hsa05415 | Diabetic cardiomyopathy | 6.60E-04 | 12 | P17252, P05141, P12236, P14598, Q15080, O15239, Q16718, O14521, P05496, Q13557, P04406, P26678 | PRKCA, SLC25A5, SLC25A6, NCF1, NCF4, NDUFA1, NDUFA5, SDHD, ATP5G1, CAMK2D, GAPDH, PLN | More | | Irbesartan | hsa05418 | Fluid shear stress and atherosclerosis | 2.18E-08 | 16 | Q16539, P42338, Q14145, P14598, P78417, P10599, P14780, P01375, P63261, P04637, P10415, P14778, P27930, P0DP23, P08238, Q92974 | MAPK14, PIK3CB, KEAP1, NCF1, GSTO1, TXN, MMP9, TNF, ACTG1, TP53, BCL2, IL1R1, IL1R2, CALM1, HSP90AB1, ARHGEF2 | More | Genes in community(ComG) | Gene name of ComG | Protein name of ComG | Co-expressed genes in pathway (PathG) | Gene name of PathG | Protein name of PathG | Coexpression |
---|
Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 1 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.78 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | 0.795 | P29375 | JARID1A | Lysine-specific demethylase 5A | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.79 | P78508 | KCNJ10 | ATP-sensitive inward rectifier potassium channel 10 | P42338 | PIK3CB | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | -0.948 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | Q14145 | KEAP1 | Kelch-like ECH-associated protein 1 | -0.733 | P29375 | JARID1A | Lysine-specific demethylase 5A | P14598 | NCF1 | Neutrophil cytosol factor 1 | 0.792 | P46091 | GPR1 | Chemerin-like receptor 2 | P78417 | GSTO1 | Glutathione S-transferase omega-1 | 0.738 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P10599 | TXN | Thioredoxin | 0.749 | P78508 | KCNJ10 | ATP-sensitive inward rectifier potassium channel 10 | P10599 | TXN | Thioredoxin | -0.707 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P10599 | TXN | Thioredoxin | 0.836 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P10599 | TXN | Thioredoxin | 0.867 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.778 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.75 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P14780 | MMP9 | Matrix metalloproteinase-9 | 0.814 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P01375 | TNF | Tumor necrosis factor | 0.732 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P01375 | TNF | Tumor necrosis factor | 0.718 | P46091 | GPR1 | Chemerin-like receptor 2 | P63261 | ACTG1 | Actin, cytoplasmic 2 | 0.776 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P04637 | TP53 | Cellular tumor antigen p53 | -0.823 | P46091 | GPR1 | Chemerin-like receptor 2 | P10415 | BCL2 | Apoptosis regulator Bcl-2 | 0.808 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.76 | P78508 | KCNJ10 | ATP-sensitive inward rectifier potassium channel 10 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | -0.877 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.778 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P14778 | IL1R1 | Interleukin-1 receptor type 1 | 0.857 | Q16539 | MAPK14 | Mitogen-activated protein kinase 14 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.811 | P78508 | KCNJ10 | ATP-sensitive inward rectifier potassium channel 10 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | -0.739 | P49841 | GSK3B | Glycogen synthase kinase-3 beta | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.848 | P25024 | CXCR1 | C-X-C chemokine receptor type 1 | P27930 | IL1R2 | Interleukin-1 receptor type 2 | 0.955 | P29375 | JARID1A | Lysine-specific demethylase 5A | P0DP23 | CALM1 | Calmodulin-1 | 0.755 | P46091 | GPR1 | Chemerin-like receptor 2 | P0DP23 | CALM1 | Calmodulin-1 | -0.846 | P29375 | JARID1A | Lysine-specific demethylase 5A | P08238 | HSP90AB1 | Heat shock protein HSP 90-beta | 0.711 | P46091 | GPR1 | Chemerin-like receptor 2 | Q92974 | ARHGEF2 | Rho guanine nucleotide exchange factor 2 | -0.815 |
| |